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SUMMARY 
The evolutionary expansion of the mammalian neocortex (Ncx) is thought to be linked to 
increased proliferative capacity of basal progenitors (BP) and their neurogenic capacity. Here, 
by quantifying BP morphology in the developing Ncx of mouse, ferret, and human, we show 
that increased BP proliferative capacity is linked to an increase in BP process number. We 
identify human membrane-bound PALMDELPHIN (PALMD-Caax) as an underlying factor and 
show that it drives BP process growth and proliferation when expressed in developing mouse 
and ferret Ncx. Conversely, CRISPR/Cas9-mediated disruption of PALMD or its binding partner 
ADDUCIN-γ in fetal human Ncx reduces BP process numbers and proliferation. We further 
show that PALMD-induced processes enable BPs to receive pro-proliferative integrin-
dependent signals. These findings provide a link between BP morphology and proliferation, 
suggesting that changes in BP morphology may have contributed to the evolutionary 
expansion of the Ncx. 
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INTRODUCTION 
The evolutionary expansion of the mammalian Ncx is thought to underlie the increased 
cognitive abilities of humans. The size of Ncx is primarily determined by the developmental 
production of neurons, which is generally governed by the proliferative capacity of neural 
stem and progenitor cells (Borrell and Reillo, 2012; Dehay et al., 2015; Florio and Huttner, 
2014; Lui et al., 2011; Molnar et al., 2006; Rakic, 2009; Sousa et al., 2017). 
 
Neural progenitors can be divided into two classes: apical progenitors (APs) and basal 
progenitors (BPs). APs reside in the ventricular zone (VZ), are highly proliferative across 
mammals and upon division can generate other APs, BPs or, rarely, neurons (Götz and 
Huttner, 2005; Rakic, 2003). 
 
BPs reside in the subventricular zone (SVZ) and show great variability in their proliferative 
capacity across mammals. In species with a small and lissencephalic (smooth) Ncx, such as 
mouse (embryonic mouse Ncx hereafter referred to as mNcx), BPs exhibit a low proliferative 
capacity, dividing typically once to generate two neurons (Haubensak et al., 2004; Miyata et 
al., 2004; Noctor et al., 2004). In species with an expanded and gyrencephalic (folded) Ncx, 
such as ferret (developing ferret Ncx hereafter referred to as fNcx) or human (fetal human Ncx 
hereafter referred to as hNcx), BPs are more proliferative and can undergo several cycles of 
proliferative divisions to generate further BPs before dividing to generate neurons (reviewed 
in (Florio and Huttner, 2014; Lui et al., 2011)). A specific type of BPs, called basal (or outer) 
radial glia (bRG), are particularly important in this context. In mouse, bRG are very rare and 
mostly neurogenic (Shitamukai et al., 2011; Wang et al., 2011), whereas in ferret and primates, 
bRG are more abundant and highly proliferative, (Betizeau et al., 2013; Fietz et al., 2010; 
Hansen et al., 2010; Reillo et al., 2011; Smart et al., 2002). The increased proliferative capacity 
of BPs, and in particular bRG, in species with an enlarged Ncx leads to SVZ expansion, resulting 
in the generation of two distinct zones: inner and outer SVZ (ISVZ and OSVZ) (Dehay et al., 
2015; Smart et al., 2002). Thus, BPs, and particularly bRG, are considered the major progenitor 
cell type underlying the evolutionary expansion of the Ncx (Borrell and Reillo, 2012; Florio and 
Huttner, 2014; Lui et al., 2011). 
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BPs in ferret and primates show diverse morphologies (Betizeau et al., 2013; Reillo et al., 
2017), some of which have also been observed in mNcx (Pilz et al., 2013; Wong et al., 2015). 
bRG were originally described as monopolar cells with a long basal process that often contacts 
the basal lamina (Fietz et al., 2010; Hansen et al., 2010; Reillo et al., 2011). A seminal study in 
macaque (Betizeau et al., 2013) has shown that bRG come in several different morphotypes 
and that the morphotype with an additional, apically directed, process might be more 
proliferative than the monopolar morphotype (Dehay et al., 2015). However, the molecular 
mechanisms regulating BP morphology and, in particular, its influence on the BP proliferative 
capacity remain largely unknown. 
 
Here we have examined the diversity of BP morphologies in three different mammalian 
species, exploring whether manipulating BP morphology will result in a modification of BP 
proliferative capacity. We propose a mechanism of how cell morphology contributes to the 
proliferative capacity of neocortical progenitors. 
  




Morphological heterogeneity of human proliferative BPs 
We first investigated the diversity of BP morphologies in the hNcx at mid-neurogenesis. We 
defined a cell in the SVZ with a SOX2+ nucleus as a proliferative BP (Figures 1A, S1A). 
Immunofluorescence (IF) for HOPX , which was found to be present in the entire cell body and 
in cell protrusions (Figures 1A, S1A), enabled us to determine BP morphology. 
 
Using these criteria, we identified 6 different morphotypes of human proliferative BPs, 5 of 
which were radial in morphology (constituting different bRG morphotypes) and the remaining 
one was multipolar (multipolar BP hereafter referred to as mBP, Figure 1A). Of the 5 radial 
morphotypes, 3 have been described previously (Betizeau et al., 2013; Fietz et al., 2010; 
Hansen et al., 2010; Reillo et al., 2011), (i) bRG with a basal process (hereafter referred to as 
bRG-b), (ii) bRG with an apical process (bRG-a), and (iii) bRG with both apical and basal 
processes (bRG-ab, Figure 1A). In addition, we also identified bRG with a bifurcated basal 
process (bRG-bbf) and bRG with an apical process plus a bifurcated basal process (bRG-abbf). 
The mBPs which exhibited small processes extending in various directions also expressed 
markers of proliferative BPs and we, hence, refer to them as proliferative mBP (mBP-p) to 
collectively comprise progenitor types previously referred to as proliferative basal 
intermediate progenitors, transit amplifying progenitors, or transient bRG (Betizeau et al., 
2013; Florio and Huttner, 2014; Lui et al., 2011). The mBP-p morphotype as well as the bRG-
bbf and bRG-abbf (collectively termed bRG-(a)bbf) were corroborated by IF for BLBP (Figure S1B, 
C). 
 
To further corroborate the bRG-(a)bbf morphotypes by an independent approach, we applied 
DiI to the basal side of hNcx tissue. This revealed all the bRG morphotypes that exhibited 
contact with the basal lamina (bRG-b, bRG-ab and bRG-(a)bbf, Figures 1B, S1D-G; see also 
supplemental movies S1-3 showing 3D representations of cells). For a more detailed cell 
biological analysis of the human bRG-(a)bbf, please refer to Figure S1H-H" and the respective 
figure legend. For the analysis of the morphology of 15-wpc human gliogenic progenitors, 
please refer to the Figure S1I-N and the respective figure legend. 
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In conclusion, we provide evidence for a morphological heterogeneity of human BPs that is 
larger than previously reported, with two additional morphotypes identified – bRG-bbf and 
bRG-abbf. The presence of two basal processes makes these morphotypes particularly 
interesting in the context of the proliferative capacity of BPs, considering that a long basal 
process has been considered a landmark of proliferative bRG (Fietz et al., 2010; Hansen et al., 
2010). 
 
Quantitative analysis of BP morphotypes across different mammals 
In light of the above observations, we (i) explored whether there were any differences in BP 
morphotypes between mammalian species, and (ii) sought to develop a quantitative method 
for analyzing BP morphology. To this end, we expressed membrane-targeted GFP (mGFP) and 
tracked BP morphology. We compared (i) the lissencephalic mouse with a small Ncx, (ii) the 
gyrencephalic ferret with an enlarged Ncx and (iii) hNcx tissue (Figure 2A-C). In both mNcx and 
fNcx, we performed in utero electroporations (IUE) of mGFP, whereas hNcx tissue was 
subjected to ex vivo electroporation of mGFP (for details including the developmental stages 
and markers used to identify BPs, see Methods and Figures 2A-C, S2C, D). Using the mGFP 
signal on 3D stacks of sufficiently thick vibratome sections, we tracked the morphology of the 
targeted BPs in order to generate 2D cell masks representing the cell shape, which were then 
used to quantify a set of morphological parameters (for details of sectioning and tracking, see 
Methods and Figure S2A, B). 
 
We first examined the relative proportion of the two major morphological classes – mBPs and 
bRG. Whereas human and ferret exhibited a roughly similar proportion of mBPs and bRG, only 
8% of the mouse BPs were bRG (Figure 2D), which was consistent with previously published 
data for mNcx (Wang et al., 2011; Wong et al., 2015). 
 
Next, we analyzed the morphology of mBPs in all three species. Human mBPs exhibited more 
primary processes (i.e. those that originate from the cell body) than mouse mBPs. 
Furthermore, human mBPs had significantly more of all processes (primary processes plus 
their branches) than mouse and ferret (Figure 2E). The branching index, calculated as the 
number of all processes divided by the number of primary processes, was also increased 
between mouse and human (Figure S2E). 
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We then analyzed the morphology of bRG. Distinguishing between the 5 bRG morphotypes 
(see Figure 1A) we observed significant differences in their distributions across the 3 species 
(Figure 2F). Additionally, when collectively quantifying bRG morphotypes with two or more 
processes vs. bRG with a single process, hNcx and fNcx showed a significantly higher 
proportion of the former than mNcx (see Methods for details). All 5 bRG morphotypes 
originally described using SOX2 and HOPX IF (see Figure 1A) were confirmed in the hNcx by 
mGFP tracking, and no additional morphotypes were identified (for examples of a bRG-bbf, see 
Figure 2C', C'', supplemental movie S4; Figure S2F). Quantification of human bRG morphotypes 
using HOPX and SOX2 IF (Figure S2G) showed very similar distribution to the one obtained 
using mGFP tracking (see Figure 2F right). Interestingly, all 5 bRG morphotypes were also 
detected in fNcx, albeit at different proportions compared to hNcx, but not in mNcx, which by 
mGFP tracking appeared to lack bRG-(a)bbf (Figure 2F). We corroborated the latter finding by 
IF for Sox2 and Hopx in mNcx (Figure S2H-J). Of note, the occurrence of specific bRG 
morphotypes does not appear to be linked to specific phases of the cell cycle, as the same 
morphotypes in similar relative proportions were found in mitotic and interphase bRG (Figure 
S2K-N). 
 
We also examined the number of radial processes per single bRG (irrespective of morphotype) 
in mNcx, fNcx and hNcx (Figure 2G). bRG in hNcx exhibited a greater average number of radial 
processes than bRG in fNcx and mNcx. In addition to the radial processes, we detected a 
number of smaller protrusions of bRG, previously termed lamellate expansions (Rakic, 1972; 
Reillo et al., 2017) in hNcx and fNcx, but not mNcx (Figures 2C", S2O, P). 
 
Taken together, these data indicate an increase (i) in the diversity of BP (especially bRG) 
morphotypes and (ii) in the number of processes that BPs grow, from mouse to ferret to 
human. This is particularly interesting for bRG in light of the differences across species in bRG 
proliferative capacity, which are thought to underlie the evolutionary expansion of the Ncx 
(Florio and Huttner, 2014; Lui et al., 2011). 
 
Cellular distribution and subcellular localization of the morpho-regulatory protein 
PALMDELPHIN (PALMD) 
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We then sought to identify molecular players that might govern BP morphology. To this end, 
we examined the published transcriptome dataset from hNcx (Fietz et al., 2012) and searched 
for genes (i) whose expression is enriched in the SVZ compared to VZ and cortical plate (CP), 
and (ii) whose protein product might have a morpho-regulatory role. This way we identified 
PALMDELPHIN (PALMD) (Figure 3A, Table S1; see Methods for details and Figure S3A for 
Palmd mRNA expression), a gene whose protein product belongs to the paralemmin family of 
morpho-regulatory proteins. Paralemmins have been shown to be implicated in the control of 
cell shape, neurite growth and filopodia extension (Arstikaitis et al., 2008; Hu et al., 2001; 
Kutzleb et al., 1998). Previous studies on Palm1, the founding member of this family, suggest 
that these functions depend on its attachment to the plasma membrane (PM) (Kutzleb et al., 
1998). Expression of the Palmd protein (Figure S3B-D) in mNcx, fNcx and hNcx was consistent 
with the published mRNA expression pattern. 
 
In all three species the Palmd gene is predicted to give rise to two mRNA splice variants (Hu 
et al., 2001) that we term Palmd-CaaX and Palmd-KKVI, corresponding to the 4 C-terminal 
amino acid residues. Palmd-CaaX shares the CaaX box with Palm1, which has been shown to 
be attached to the PM via CaaX box-dependent palmitoylation (Gauthier-Campbell et al., 
2004; Hu et al., 2001). This in turn suggests that Palmd-CaaX may also be PM-bound. In 
contrast, Palmd-KKVI is not likely to exhibit a PM localization. Examination of the 
transcriptome dataset from mNcx and hNcx (Florio et al., 2015) revealed that in hNcx both 
isoforms are expressed in roughly equal amounts, whereas in mouse only the Palmd-KKVI 
mRNA exhibits robust expression (Figure S3E). 
 
To investigate the subcellular localization of the human PALMD protein isoforms, we 
generated three different constructs encoding human PALMD-CaaX, PALMD-KKVI and 
PALMD-', which is a truncated version of human PALMD lacking the 14 C-terminal residues 
(Figure 3B), and expressed these proteins in mouse EpH4 cells. PALMD-CaaX showed a clear 
association with the PM, whereas PALMD-KKVI and PALMD-' exhibited a cytoplasmic 
localization (Figure 3C, D). 
 
We next examined the subcellular localization of the endogenous Palmd protein in the SVZ 
cells of mNcx and hNcx by electron microscopy (EM). In mNcx (Figure 3E left) we detected 
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Palmd in the cytoplasm. In hNcx (Figure 3E right), in addition to cytoplasmic localization, we 
detected PALMD at the PM, particularly on cell processes. We corroborated these data by IF 
analysis (see Figure S3F, G for details). 
 
Taken together, these data suggest that the expression levels of the Palmd-CaaX, which in 
contrast to the Palmd-KKVI is characteristically associated with the PM, are higher in the SVZ 
of species with a greater abundance of BPs extending numerous processes. We therefore 
chose to examine the potential ability of human PALMD-CaaX to induce BP process growth. 
 
PALMD-CaaX induces BP process growth in mNcx and fNcx 
We performed IUE of human PALMD-CaaX along with mGFP in E13.5 mNcx and observed a 
subcellular localization pattern reminiscent of association with PM (Figure S3H). We identified 
BPs by Ki67 IF (Figure 3F) and examined the effects of PALMD-CaaX on mouse BP morphology. 
The proportion of mBP and bRG was not altered (Figure S3I). However, we detected a marked 
increase in the number of both primary and total mBP processes upon IUE of PALMD-CaaX 
(Figure 3G), which was accompanied by an increase in mBP process branching (Figure S3J). In 
contrast, no significant differences were found when analyzing bRG radial processes (Figure 
3H). Both, a Sholl analysis and measuring the length of mBP processes, revealed that the 
PALMD-CaaX predominantly induced short process (Figure S3K, L). 
 
We then examined the ability of PALMD-CaaX to induce bRG process growth in a potentially 
more conducive environment by expressing it in the fNcx (Figure S3M, N). Indeed, PALMD-
CaaX changed the distribution of bRG morphotypes in fNcx (Figure 3J, see Figure 3I for an 
example of a bRG-bbf), rendering it similar to the distribution in hNcx (see Figure 2F right). 
Furthermore, quantification of BP processes revealed an almost 2-fold increase in both mBP 
and bRG process numbers (Figure 3K, L) and mBP branching index (Figure S3O). These findings 
indicate that in contrast to mNcx, PALMD-CaaX is sufficient to increase bRG processes in fNcx. 
Of note, PALMD-CaaX did not induce new radial process of APs in either mNcx or fNcx (Figure 
S3P), suggesting that this increase is specific to BPs. 
 
Comparing the effects of PALMD-CaaX, PALMD-KKVI and PALMD-' in mNcx, we found that 
the latter two were not able to increase the number of BP processes (Figure 3M), indicating 
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that the ability to elicit this feature is specific for PALMD-CaaX. Finally, analysis of mitotic mBPs 
(using PhVim IF) in mNcx revealed that the PALMD-CaaX–induced processes persisted through 
mitosis (Figure 3N). PALMD-CaaX caused a four-fold increase in mitotic mBP processes (Figure 
3O), which appeared to be short and relatively thin (Figure S3Q). Furthermore, analysis of the 
morphology of mitotic BPs (identified by PH3 IF) in fNcx upon IUE of PALMD-CaaX revealed a 
marked increase in the number of processes of mitotic mBPs and bRG (Figure 3P-S). 
 
Taken together, these data show that PALMD-CaaX is sufficient to induce BP processes in both 
mNcx and fNcx. Importantly, only the PM-bound isoform of PALMD was able to induce such 
processes. 
 
PALMD-CaaX promotes BP proliferation in mNcx and fNcx 
In light of the above findings (see Figures 2 and 3), we examined BP proliferation upon PALMD-
CaaX expression in mNcx. IF for PhVim and Ki67 of E15.5 mNcx (Figure S4A), revealed a specific 
increase in basal mitoses (PhVim+ cells, Figure 4A) and a marked increase in the proportion of 
cycling BPs (Ki67+ cells, Figure 4B) upon PALMD-CaaX IUE. These findings were further 
corroborated by analysis of cell cycle re-entry using a single EdU pulse at E14.5 followed by an 
IF analysis for Ki67 at E15.5, which revealed a doubling of BP cell cycle re-entry upon IUE of 
PALMD-CaaX (Figure 4C, D). These data indicated that IUE of PALMD-CaaX induces mouse BPs 
to undergo repeated cycles of cell divisions (likely symmetric proliferative ones), as opposed 
to their typical single, differentiative cell division (Haubensak et al., 2004; Miyata et al., 2004; 
Noctor et al., 2004). 
 
We also examined BP proliferation in the fNcx and found an increase in the number of basal 
mitoses upon IUE of PALMD-CaaX, as revealed by both PhVim (Figure 4E, F) and PH3 IF (Figure 
S4B, C). This increase pertained also to bRG (Figure 4G), indicating that in fNcx, in contrast to 
mNcx, human PALMD-CaaX is able to promote the generation of bRG. 
 
We then compared the effects on BP proliferation upon IUE of PALMD-CaaX, PALMD-KKVI and 
PALMD-' in the mNcx. Strikingly, only PALMD-CaaX was able to elicit a specific increase in 
basal mitoses (Figures 4H, I, S4D). Taken together, IUE of PALMD induced BP processes and 
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promoted BP proliferation in mNcx and fNcx, and both of these phenotypes were specific to 
the PM-bound PALMD-CaaX isoform. 
 
Palmitoylation of PALMD-CaaX is required for the increase in BP processes and proliferation 
We next investigated if these two PALMD-CaaX–elicited phenotypes reflected two 
independent actions of the PALMD protein, or one primary action which in turn led, as a 
consequence, to the second one. To this end we first analyzed the mNcx 16 h after IUE of 
PALMD-CaaX and found an increase in the number of BP processes (Figure 5A, C left), but did 
not see a significant effect on BP proliferation as revealed by IF for Ki67 (Figure 5A, D left). 
These data suggest that the PALMD-CaaX–induced increase in BP processes precedes the 
PALMD-CaaX–promoted increase in BP proliferation. 
 
Paralemmins are known to attach to the PM via palmitoylation (Arstikaitis et al., 2008; 
Gauthier-Campbell et al., 2004). To block protein palmitoylation including that of PALMD-
CaaX, we isolated mNcx hemispheres 16 h after IUE of PALMD-CaaX and incubated them for 
24 h ex vivo in the presence or absence of the palmitoylation inhibitor 2-bromopalmitate 
(2BrPal) (Figure 5B and see Methods). In the absence of 2BrPal, the PALMD-CaaX–expressing 
hemispheres maintained the increase in mBP process number (Figure 5C middle), which was 
now followed by increased BP proliferation (Figure 5D middle). In contrast, upon 2BrPal 
treatment, not only was the increase in mBP process number reverted to control levels (Figure 
5C right), but also no increase in BP proliferation occurred (Figure 5D right). These data 
provide further evidence that PALMD-CaaX palmitoylation, and hence its PM attachment, are 
essential for the PALMD-CaaX–induced increase in BP process number and proliferation. They 
are also consistent with the notion that the increase in BP proliferation is a consequence of 
the increase in BP process number. 
 
We then investigated the general relevance of protein palmitoylation, including that of 
endogenous PALMD-CaaX, for BP process growth and proliferation in hNcx by ex vivo 
incubation with 2BrPal (Figure 5E and see Methods). Although 2BrPal treatment did not 
change the distribution of bRG morphotypes (Figure S5A), protein palmitoylation was found 
to be required to maintain the normal levels of mBP process number and of cycling BPs in 
hNcx tissue (Figure 5F, G). 
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PALMD ablation in hNcx reduces BP process number and proliferation 
We asked if the endogenously expressed PALMD was required for the maintenance of the BP 
processes in hNcx. To this end, we employed the CRISPR/Cas9 technology and successfully 
disrupted the expression of the PALMD gene (hereafter referred to as PALMD KO) in 10-13–
wpc hNcx tissue ex vivo (for details of the KO design, see Figure S5B, C, and Methods; for the 
efficiency and details of the ex vivo manipulation, see Figure S5D-H and Methods). 
 
Analysis of the BP morphotypes in hNcx revealed that PALMD KO did not affect the proportion 
of mBP and bRG (Figure S5I), but clearly affected the proportions of distinct bRG morphotypes 
(Figure 5I). Specifically, we detected an increase in the proportion of bRG-b, at the expense of 
morphotypes with two and more processes. Furthermore, the number of mBP processes was 
reduced (Figure 5J), as was the number of radial processes of bRG (Figure 5K). The branching 
index of mBPs was not affected in a statistically significant manner (Figure S5J). Taken 
together, these data indicate that the depletion of the endogenous PALMD is sufficient to 
reduce the number of BP processes, in turn implying that PALMD is an essential factor for 
maintaining the normal level of such processes. 
 
In light of this, we investigated the potential effect of PALMD KO on human BP proliferative 
capacity, by quantifying the proportion of progenitors (PCNA+ cells) among the Cas9+ 
abventricular cells (all Cas9+ cells without contact to the ventricle, see Figure 5H). PALMD KO 
resulted in a significant reduction of PCNA+ abventricular cells (Figure 5L). Hence, PALMD is 
also an essential factor for maintaining the normal level of cycling BPs. 
 
Palm1, in contrast to PALMD-CaaX, is not essential for BP process number and proliferation 
Our results on the lack of effect of a Palm1 KO on BP process number and proliferation in 
mNcx, described in detail in Figure S6A-D, indicate that the human PALMD-CaaX–induced BP 
process growth and proliferation are specific to this member of the paralemmin family. 
 
PALMD is complexed with adducin 3 
We next sought to obtain mechanistic insight into how PALMD-CaaX elicits the increase in BP 
process number. Immunoprecipitation (IP) of PALMD under stringent conditions from hNcx 
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tissue followed by mass spectrometry (MS) (Figure 6A, Table S2) revealed that PALMD 
specifically interacts with proteins that anchor the actin cytoskeleton to the PM, in particular 
adducins (Kiang and Leung, 2018). Among the adducins, only Add3 (adducin-J) shows an 
mRNA expression pattern in mNcx and hNcx that resembles that of Palmd mRNA (see Figure 
S6E for details, and compare to Figure S3A). Consistent with this, IF for Add3 showed 
prominent presence in fNcx, but not mNcx (Figure S6F, G). Complementing these 
observations, we found Add3 to be present in IP of Palmd from fNcx, but not from mNcx 
(Figure 6A, Table S2). 
 
We sought to further corroborate the existence of a PALMD-ADD3 complex by performing IP 
of either PALMD or ADD3 under stringent conditions from hNcx tissue. Indeed, we detected 
PALMD upon ADD3 IP and ADD3 upon PALMD IP (Figures 6B, S6H). Collectively, our data 
indicate the existence of a Palmd-Add3 complex in hNcx and fNcx, but not mNcx. In light of 
the function of Add3 to anchor the actin cytoskeleton to the PM, this complex likely exerts a 
key role in the PALMD-CaaX–induced BP process growth. 
 
We examined a potential role of ADD3 itself in BP process growth and proliferation, by 
performing a CRISPR/Cas9-mediated KO of ADD3 in hNcx tissue (Figures 6C, S6I, J, see 
Methods for details). ADD3 KO resulted in an altered distribution of bRG morphotypes (Figure 
6D) which was essentially similar to the one obtained after the PALMD KO in hNcx tissue (see 
Figure 5I). Furthermore, ADD3 KO resulted in reduction not only of the number of mBP 
processes (Figure 6E), but also in the level of cycling BPs (Figure 6F), again very similar to what 
we had observed upon PALMD KO in hNcx tissue. Taken together with our observation that 
membrane attachment of PALMD-CaaX is required for BP process growth (Figure 3M) and 
proliferation (Figure 4I), these data show that a PALMD-CaaX/ADD3 complex underlies these 
two phenotypes in hNcx. 
 
PALMD-CaaX expression results in an increase in upper-layer (UL) neurons 
We next explored putative effects of PALMD-CaaX on UL neurons, whose increase is 
considered a hallmark of the evolutionary expansion of Ncx (Molnar et al., 2006; Rakic, 2009; 
Sousa et al., 2017). We expressed PALMD-CaaX and GFP in mNcx at E13.5 and analyzed the CP 
at E18.5 by IF for a neuronal marker Satb2, present in UL neurons (Britanova et al., 2008; 
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Leone et al., 2015) (Figure 6G). The analysis showed an altered distribution of both GFP+ and 
Satb2+ GFP+ cells, with an increase in proportion of these cells in ULs (Figure 6H, I). Moreover, 
the proportion of GFP+ cells that were Satb2+ was also increased upon IUE of PALMD-CaaX 
(Figure 6J). In line with this, we detected an increase in thickness of the ULs of the CP (Figure 
6K). Hence, human PALMD-CaaX is able to elicit a hallmark of the evolutionary expansion of 
the Ncx when expressed in mNcx. 
 
PALMD-CaaX promotes BP proliferation via integrin signaling 
We finally sought to obtain insight into the mechanism that underlies the PALMD-CaaX-
promoted BP proliferation. BPs receive a variety of pro-proliferative signals from the 
extracellular environment via their processes, notably signals involving the extracellular 
matrix (ECM) (Fietz et al., 2012). ECM-promoted proliferation of both bRG (Fietz et al., 2010) 
and mBPs (Stenzel et al., 2014) has been shown to be mediated via integrin signaling. 
 
We examined a potential role of integrin signaling in mediating PALMD-CaaX–promoted BP 
proliferation in mNcx, by focusing on integrin-E1 (Itgb1) (Loulier et al., 2009; Radakovits et al., 
2009). We detected an increase in activated Itgb1 in the SVZ of mNcx upon IUE of PALMD-
CaaX (Figure 7A, B). 
 
Downstream pro-proliferative signaling upon integrin activation is known to involve PI3K-Akt 
and MEK-ERK pathways (Moreno-Layseca and Streuli, 2014). Analysis of IF for phospho-Akt 
and phospho-ERK (markers of active PI3K-Akt and MEK-ERK pathways, respectively) (Figures 
S7A, B, 7C) showed that IUE of PALMD-CaaX led to activation of both of these pathways in 
mouse BPs. These data demonstrate that activation of both integrins and the downstream 
signaling pathways in BPs is increased upon IUE of PALMD-CaaX in mNcx. 
 
We performed an RNAi-mediated knock-down (KD) of Itgb1 in mNcx subjected to IUE of 
human PALMD-CaaX thereby reducing the level of activated Itgb1 in the SVZ to on average 
37% of control (Figure S7C-E). IF analysis for PH3 and Ki67 revealed that this reduction resulted 
in a marked decrease in the abundance of basal mitoses and cycling BPs (Figure 7D-F). In fact, 
comparison with the effect of IUE of PALMD-CaaX on the levels of Ki67+ (Figure 4B) and PH3+ 
(Figure 4I) BPs revealed that the Itgb1 KD was sufficient to reduce the PALMD-CaaX–promoted 
Kalebic et al, confidential manuscript 
 15 
increase in BP proliferation back to the control levels. Hence, Itgb1 is required for the PALMD-
CaaX–promoted increase in mouse BP proliferation. 
 
To complement these data, we showed by EM that Itgb1 was actually localized to BP processes 
in both mNcx and hNcx (Figure 7H, I). We also demonstrated that ITGB1 in hNcx is required 
for progenitor proliferation (Figure S7F, G, see Methods for details). 
 
Taken together, our data (Figures 3-6) suggested that the PALMD-CaaX-promoted increase in 
BP proliferation is the consequence of the PALMD-CaaX-induced increase in BP process 
growth. Accordingly, one would expect that the Itgb1 KD should not affect the PALMD-CaaX-
induced increase in the number of BP processes. Indeed, tracking the morphology of the mBPs 
upon Itgb1 KD in mNcx revealed that this was the case (Figure 7G). This in turn is consistent 
with our concept that increasing BP process number underlies the observed increase in BP 
proliferative capacity. 
  




Our study identifies a role of BP morphology that contributes in a major way to the differential 
proliferative capacity of BPs across mammals. Specifically, our data indicate that an increase 
in the number of BP processes leads to an increase in the proliferative capacity of BPs. In this 
regard, four aspects of our study deserve particular discussion: (i) the increase in the number 
of BP processes in the context of the evolutionary expansion of the Ncx; (ii) PALMD as an 
inducer of BP process growth, and its likely mechanism of action; (iii) the evidence that the BP 
morphology underlies BP proliferative capacity; and (iv) the requirement of Itgb1 for this 
increase in BP proliferative capacity. 
 
BP process increase in the context of the evolutionary expansion of the Ncx 
The evolutionary expansion of the Ncx is thought to be largely due to an increase in the 
proliferative capacity of BPs (Florio and Huttner, 2014; Lui et al., 2011). Here, we uncover that 
an increase in the number of BP processes constitutes a characteristic feature of this 
evolutionary expansion. First, we show that BPs contain more processes in hNcx than in fNcx 
and mNcx. Second, we show that both hNcx and fNcx exhibit a greater proportion of bRG 
morphotypes containing two or more processes compared to mNcx. Third, among these bRG 
morphotypes, the two morphotypes identified in the present study, bRG-(a)bbf, appear to be 
especially increased in relative proportion in hNcx compared to fNcx. We therefore conclude 
that the greater the number of BP processes, the more expanded the Ncx. As an increase in 
UL neurons is a hallmark of Ncx expansion (Hutsler et al., 2005; Molnar et al., 2006), the 
increase in UL neurons observed upon IUE of PALMD-CaaX in mNcx is consistent with this 
conclusion. We are aware of the fact that in the phylogenetic tree, human is closer to mouse 
than ferret (Bininda-Emonds et al., 2007). Yet, we believe that the present comparison of BP 
morphology in these 3 species allows us to draw general conclusions about the role of 
increasing BP processes in Ncx evolution. In essence, we propose the concept, mechanistically 
discussed below, that increasing the number of BP processes can expose BPs to more pro-
proliferative signals from their surrounding environment, ultimately leading to an increase in 
their proliferation. 
 
PALMD as an inducer of BP process growth, and its likely mechanism of action 
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We identified the human morpho-regulatory protein PALMD, a member of the paralemmin 
family, as being necessary and sufficient to increase BP process number. In agreement with 
previous studies on other paralemmins (Arstikaitis et al., 2008; Kutzleb et al., 1998), several 
lines of evidence suggest that PALMD-CaaX induces BP process growth via modulation of the 
PM–actin cytoskeleton interaction. 
 
First, IUE of only PALMD-CaaX isoform induced BP process growth in vivo, with the CaaX motif 
found to exert an essential role. This motif has previously been shown to mediate PM 
attachment via palmitoylation and prenylation (Gauthier-Campbell et al., 2004; Kutzleb et al., 
1998), with the former modification shown to be involved in cell process formation, notably 
neurite outgrowth (Fukata and Fukata, 2010). In line with this, we show that upon specifically 
blocking palmitoylation, PALMD-CaaX loses the ability to induce new BP processes. Therefore, 
we propose a model in which the first step in the mechanism underlying the PALMD-induced 
BP process growth is the palmitoylation of PALMD-CaaX and its PM attachment (Figure 7J). 
 
Second, a KO of PALMD in hNcx tissue reduced BP process number. Remarkably, this reduction 
was recapitulated upon KO of ADD3. Adducins are known to function in anchoring the actin 
cytoskeleton to the PM (Kiang and Leung, 2018). Hence, our findings strongly suggest that the 
observed increase in BP processes involves a PALMD-CaaX–modulated, adducin-mediated 
interaction of the actin cytoskeleton with the PM (Figure 7J). 
 
Third, we note that the PALMD-CaaX–induced processes exhibited a high level of stability. This 
was evident when analyzing mBPs in mitosis. In contrast to normally rounded up mitotic mBPs, 
PALMD-CaaX–expressing mitotic mBPs maintained an increased number of processes. In light 
of previous findings with neurons (Gauthier-Campbell et al., 2004; Kutzleb et al., 1998), we 
therefore conclude that PALMD-CaaX expression not only results in an increase in mBP 
processes but also in their stabilization, the latter reflecting a robust interaction of the actin 
cytoskeleton with the PM (Figure 7J). 
 
BP morphology underlies BP proliferative capacity 
A key question regarding the interpretation of our data is whether the increase in BP 
proliferative capacity observed upon PALMD-CaaX expression is independent of the PALMD-
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CaaX–induced increase in BP processes, or is the consequence of the latter. The following 
findings, when taken together, strongly suggest that the second scenario applies. 
 
First, the PM attachment is required for both PALMD-mediated increase in BP process number 
and proliferation. This is evident from (i) our finding that only the PM-bound PALMD-CaaX, 
but not the cytosolic PALMD-KKVI can affect both BP features and (ii) that both phenotypes 
depend on PALMD palmitoylation. Furthermore, blocking palmitoylation in hNcx tissue 
reduced both the endogenous level of BP processes and that of cycling BPs, both of which 
reflected (at least in part) the presence of the endogenous human PALMD protein. 
 
Second, the increase in BP process number preceded the increase in the level of cycling BPs 
upon IUE of PALMD-CaaX in mNcx. 
 
Third, a KO of ADD3 in hNcx tissue reduced the level of cycling BPs, in a very similar manner 
as KO of PALMD. Adducins link the actin cytoskeleton to the PM and their involvement in cell 
proliferation is thought to occur indirectly via this cytoskeletal role (Kiang and Leung, 2018). 
Hence, the PALMD KO and the ADD3 KO phenotypes are most easily reconciled with one 
another by the concept that the reduction in BP process number constitute primary effects 
 of both KOs, reflecting the lack of the normally occurring concerted action of PALMD and 
ADD3 at the PM (Figure 7J). The reductions in the level of cycling BPs upon PALMD KO and 
ADD3 KO would then reflect consequences of the reduction in BP process number. 
 
How could the PALMD-CaaX–induced BP process growth lead to an increase in BP proliferative 
capacity? In addressing this question, it should be noted that increasing two distinct types of 
BP processes, the long basal processes of bRG and short processes of both bRG and mBPs, 
exert similar effects on promoting BP proliferation. 
 
Long basal processes of bRG allows them to receive signals from the ECM components located 
at the basal lamina, which was shown to be important for proliferative capacity (Fietz et al., 
2010). Hence, growing a second basal process, as is the case for the bRG-(a)bbf morphotypes 
identified here, would allow each of the two daughters arising from the cell division of these 
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bRG to grow a basal process reaching the basal lamina, and is therefore likely to further 
promote the proliferative capacity of these BPs. 
 
Short processes of mBPs and the apically directed process of bRG-ab and bRG-abbf enable 
these BPs to receive signals from the local environment. A previous study (Betizeau et al., 
2013) has linked the presence of an apically directed process to the greater self-renewing 
potential of bRG-ab compared to bRG-b, in line with the notion that the local environment of 
BPs contains pro-proliferative signals. In agreement with this, our data demonstrate an 
increase in the number of short processes from mouse to human. The increase in the number 
of short processes of PALMD-CaaX–expressing mouse mBPs leads to an increase in the 
proliferative capacity of these cells, which provides further support for the notion that an 
increased ability to receive signals from the local SVZ environment can be conducive for BP 
proliferation. Of note, such local signals in the SVZ could, again, be provided by certain ECM 
components (Figure 7J), found to be enriched in hNcx BPs (Florio et al., 2015; Pollen et al., 
2015). 
 
Requirement of Itgb1 for the PALMD-CaaX-elicited increase in BP proliferative capacity 
If the concept is true that increased BP process growth allows BPs to receive more pro-
proliferative signals from their surrounding environment, notably involving ECM components, 
then one would expect that integrins, the major class of ECM receptors, are involved in the 
pro-proliferative signaling. Our data showing that Itgb1 is required for the BP proliferation 
increase observed upon PALMD-CaaX expression are in line with previous studies which found 
that integrin signaling promotes proliferation of cortical progenitors, notably of BPs (Fietz et 
al., 2010; Loulier et al., 2009; Stenzel et al., 2014). Importantly, reducing BP proliferative 
capacity by Itgb1 KD did not lead to a decrease in BP process number, which again is consistent 
with the notion that BP proliferation is downstream of BP morphology, and not vice versa. 
 
There are several scenarios that can explain how the presence of actin in the proximity of the 
PM, may further Itgb1 activation (Figure 7J). First, integrins are known to be transported to 
cell protrusions such as filopodia by unconventional myosins, i.e. actin-based motors (Zhang 
et al., 2004). Consistent with this, we indeed detected Itgb1 on cell processes of SVZ cells. 
Second, recent models suggest that exertion of force by the actin cytoskeleton alone may 
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contribute to integrin activation (Li and Springer, 2017). Third, the major activators of 
integrins, talins, are also well-known actin-binding proteins (Klapholz and Brown, 2017). Thus, 
anchoring of the actin cytoskeleton to specific sites of the PM by the PALMD-CaaX–ADD3 
interplay could facilitate the interaction of talin with Itgb1, which in turn would lead to its 
activation. 
 
Activated integrins are in a high affinity state to bind their ECM ligands, which would trigger 
intracellular signaling downstream of integrins. The signaling upon PALMD-CaaX–promoted 
Itgb1 activation involved the PI3K-Akt and MEK-ERK pathways (Figure 7J), which are known to 
promote cell cycle progression (Moreno-Layseca and Streuli, 2014). In agreement with this, 
we show that human PALMD-CaaX is sufficient to promote cell cycle re-entry when expressed 
in mouse BPs. Interestingly, it has been shown that mutations of several molecules in the PI3K-
Akt pathway are known to cause different neurodevelopmental disorders in human Ncx, 
including microcephaly (Hevner, 2015). It therefore appears worthwhile to explore whether 
genetic mutations of the components of the BP morpho-regulatory machinery studied here 
may underlie such disorders of so far unknown cause. 
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MAIN FIGURE TITLES AND LEGENDS 
 
Figure 1. Morphotypes of human proliferative BPs. 
(A) DAPI staining and IF for SOX2 and HOPX showing 6 morphotypes of human proliferative 
BPs (see schemes) in the OSVZ of 15-wpc hNcx (maximum intensity projection (MIP)). All 
images are oriented with the apical side facing down. Dashed lines, cell contours; arrows, basal 
processes; solid arrowheads, apical processes; open arrowheads, short processes of mBPs. 
(B) Sparse DiI labeling of 12-wpc hNcx (MIP, stitched image (StI)). Box, bRG-abbf shown at 
higher magnification in (B') at 3 different orientations as indicated. 
(A, B) Scale bars, 10 μm (A, B'), 50 μm (B). 
Seen also Figure S1 and Movies S1-S3. 
 
Figure 2. Quantitative analysis of BP morphotypes in mNcx, fNcx and hNcx. 
(A, B) DAPI staining and IF for GFP and PCNA of mNcx and fNcx upon IUE with mGFP as 
indicated. Arrowheads, examples of mGFP+ PCNA+ BPs. 
(C) DAPI staining and IF for GFP and PCNA of hNcx tissue electroporated ex vivo with mGFP 
and soluble GFP as indicated. Box, bRG-bbf shown at higher magnification in (C') and (C''). (C'') 
MIP of 8 optical sections (left) and lower magnification MIPs of the same bRG-bbf along with 
the respective cell mask at 3 different orientations as indicated (right). Solid arrowheads, bRG-
bbf; arrows, basal processes, note that the shorter basal process terminates with a growth 
cone-like structure (double arrow); open arrowheads, short processes leaving the cell body. 
(D-G) Quantitative analyses of BP morphotypes in E15.5 mNcx, E35 fNcx and 10-13–wpc hNcx, 
tracked by mGFP IF as described in (A-C). 
(D) Distribution of bRG vs. mBP. 
(E) Quantification of processes per single mBP. 
(F) Distribution of the 5 bRG morphotypes, as shown schematically on the right. 
(G) Quantification of radial processes per single bRG. 
(A-C) Single optical sections (SOpS) (except for (C'')), StIs. Scale bars, 50 μm (A-C), 10 µm (C', 
C'' left), 30 µm (C'' three right panels). 
(D-G) Mean of 8 (mouse D, E), 13 (mouse F, G), 4 (ferret) and 7 (human) experiments. Total 
number of cells scored: mouse 88 (D), 80 (E), 14 (F, G); ferret 88 (D), 43 (E), 45 (F, G); human 
90 (D), 48 (E), 42 (F, G). Error bars, confidence interval (CI); ****, P <0.0001; ***, P <0.001; **, 
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P <0.01; *, P <0.05; n.s., not statistically significant; two-way ANOVA with Bonferroni post-hoc 
tests (D, F), Student's t-test (E, G). 
See also Figure S2 and Movies S4,5. 
 
Figure 3. PALMD-CaaX induces BP process growth in mNcx and fNcx. 
(A) Sequential steps in the analysis of the transcriptome dataset of hNcx (Fietz et al., 2012), 
leading to the identification of PALMD. 
(B) Human PALMD isoforms used for expression. Green and orange boxes, last protein-coding 
exons of PALMD-CaaX and of PALMD-KKVI, respectively. PALMD-', truncated version lacking 
the last protein-coding exon. 
(C) DAPI staining and IF for GFP and PALMD of EpH4 cells 2 days after transfection with GFP 
and control or different PALMD isoforms as indicated. 
(D) Quantification of EpH4 cells that exhibit PM localization of PALMD, upon transfections as 
indicated. 
(E) EM showing localization of Palmd in the cytoplasm of an SVZ cell body (upper left) and of 
a radial process in the VZ (lower left) of E14.5 mNcx, and on the PM of a process (upper right) 
and in the cytoplasm (lower right) of SVZ cells of 11-wpc hNcx. Arrows, Palmd in cytoplasm; 
arrowheads PALMD on PM. 
(F-S) Analyses of mNcx (F-H, M-O) and fNcx (I-L, P-S) upon IUE with mGFP and control or 
PALMD isoforms as indicated. (G, H, J-M, O, R, S) Quantification of processes of BPs as tracked 
by mGFP IF. 
(F) DAPI staining and IF for GFP and Ki67. Open arrowheads, cell processes. 
(G, H) Quantification of processes per single mouse mBP (G) and of radial processes per single 
mouse bRG (H). 
(I) IF for GFP and Pax6 of a ferret bRG-bbf upon PALMD-CaaX IUE as indicated. Arrows, basal 
processes. 
(J) Distribution of the 5 ferret bRG morphotypes, as shown schematically on the right. 
(K, L) Quantification of processes per single ferret mBP (K) and of radial processes per single 
ferret bRG (L). 
(M) Quantification of primary and all processes per single mouse mBP upon IUE with mGFP 
and control or different PALMD isoforms as indicated. 
(N) DAPI staining and IF for GFP, Ki67 and PhVim. Arrowheads, cell processes. 
Kalebic et al, confidential manuscript 
 28 
(O) Quantification of primary and all processes per single mouse mitotic mBP. 
(P, Q) Ferret mitotic mBP (P) and bRG (Q). DAPI staining and IF for GFP and PH3. Dashed lines, 
cell body. In (Q): Arrow, basal process; arrowhead, apical process. 
(R, S) Quantification of primary and all processes per single ferret mitotic mBP (R) and of radial 
processes per single ferret mitotic bRG (S). 
(C, E, F, I, N, P, Q) SOpS. Images are oriented with the apical side facing down (except C). Scale 
bars, 50 μm (C), 20 μm (F), 10 μm (I, N, P, Q), 100 nm (E). Cell shapes as tracked by mGFP IF 
are depicted along the IF images in (F, I, N, P, Q; note that cell shapes in (I, Q) are reduced in 
size relative to the IF images). 
(D, G, H, J-M, O, R, S) Mean of 3 (M), 4 (D, J-L), 5 (R, S), 8 (G, H, O) experiments. Total number 
of cells scored: control 80 (G), 8 (H), 35 (J, L), 31 (K), 30 (M), 9 (O), 10 (R), 11 (S); PALMD-CaaX 
89 (D), 79 (G), 8 (H), 41 (J, L), 34 (K), 35 (M), 17 (O), 8 (R), 13 (S); PALMD-KKVI 85 (D), 30 (M); 
PALMD-' 84 (D), 30 (M). Error bars, SD (D, R, S) or CI (G, H, J-M, O); ****, P <0.0001; ***, P 
<0.001; **, P <0.01; *, P <0.05; n.s., not statistically significant; one-way ANOVA with 
Bonferroni post-hoc test (D), two-way ANOVA with Bonferroni post-hoc test (J), Student's t-
test (G, H, K-M, O, R, S). 
See also Figure S3 and Table S1. 
 
Figure 4. PALMD-CaaX promotes BP proliferation in mNcx and fNcx. 
Analyses of mNcx (A-D, H, I) and fNcx (E-G) upon IUE with mGFP and control or PALMD 
isoforms as indicated. 
(A) Quantification of mGFP+ PhVim+ mitoses. 
(B) Percentage of mGFP+ cells in SVZ+IZ that are Ki67+. 
(C, D) Following IUE, embryos were subjected to a single EdU pulse at E14.5, followed by DAPI 
staining and IF for GFP, Ki67 and EdU at E15.5. (C) Overviews of electroporated area. 
(D) Percentage of EdU+ GFP+ cells in SVZ+IZ that are Ki67+. 
(E) DAPI staining and IF for GFP and PhVim. Vertical arrows, apical mitoses; horizontal arrows, 
basal mitoses; arrowheads, bRG-ab. 
(F) Quantification of mGFP+ PhVim+ mitoses. 
(G) Percentage of mitotic BPs that are bRG. 
(H) DAPI staining and IF for GFP and PH3. 
(I) Quantification of basal mGFP+ PH3+ mitoses. 
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(C, E, H) SOpS, StIs. Scale bars, 50 μm (C), 20 μm (E, H). 
(A, B, D, F, G, I) Mean of 5 (A, D, F, G), 3 (B), 8 (I, control and PALMD-CaaX), 4 (I, PALMD-KKVI 
and PALMD-') experiments. Error bars, SD; **, P <0.01; *, P <0.05; n.s., not statistically 
significant; Mann-Whitney U-test. 
See also Figure S4. 
 
Figure 5. PALMD and its palmitoylation are required for the BP process growth and 
proliferation. 
(A-D) Analyses of mNcx hemispheres 16 h after IUE with mGFP and control or PALMD-CaaX as 
indicated, either directly (A, C left, D left) or after incubation ex vivo for 24 h in the absence 
(DMSO; B left, C middle, D middle) or presence (2BrPal; B right, C right, D right) of 2BrPal. 
(A, B) DAPI staining and IF for GFP and Ki67. Arrows, cell processes; dashed lines, cell body. (A) 
boxes, area shown at higher magnification on the right. 
(C) Quantification of processes per single mBP. 
(D) Percentage of mGFP+ cells in SVZ+IZ that are Ki67+. 
(E-G) hNcx tissue was electroporated ex vivo with mGFP and soluble GFP, kept in culture and 
incubated in the absence (DMSO) or presence of 2BrPal as indicated in (E). 
(E) DAPI staining and IF for GFP and PCNA of a bRG (top) and mBP (bottom). Arrowheads, cell 
bodies; arrows, cell processes. 
(F) Quantification of processes per single mBP. 
(G) Abventricular GFP+ cells that are PCNA+, expressed as percentage of control. 
(H-L) hNcx tissue was electroporated ex vivo with mGFP and soluble GFP together with 
plasmids encoding Cas9_T2A_RFP and gRNA targeting either LacZ (Control) or PALMD (PALMD 
KO), as indicated. 
(H) DAPI staining and IF for GFP, RFP (reflecting Cas9) and PCNA. Boxes (30 x 30 μm), areas 
shown at higher magnification on the right. 
(I) Distribution of the 5 bRG morphotypes, as shown schematically on the right. 
(J, K) Quantification of processes per single mBP (J) and of radial processes per single bRG (K). 
(L) Abventricular Cas9+ cells that are PCNA+, expressed as percentage of Control. 
(A, B, E, H) SOpS (A, B), MIPs (E, H), StIs (A, B, H). Scale bars, 50 μm (H), 30 µm (A), 20 µm (B), 
10 µm (E). 
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(C, D, F, G, I-L) Mean of 6 (I-K), 4 (L) or 3 (C, D, F, G) experiments. Total number of cells scored: 
control 15 (C-16h, C-DMSO), 19 (C-2BrPal), 31 (I), 35 (J), 31 (K); PALMD-CaaX 15 (C-16h), 16 (C-
2-BrPal), 26 (C-DMSO); PALMD KO 28 (I), 31 (J), 28 (K); DMSO in (F) 25; 2BrPal in (F) 18. Error 
bars, CI (C, F, I-K) or SD (D, G, L); ***, P <0.001; **, P <0.01; *, P <0.05; n.s., not statistically 
significant; Student's t-test (C, F, G, J, K), Mann-Whitney U-test (D, L), two-way ANOVA with 
Bonferroni post-hoc tests (I). 
See also Figure S5. 
 
Figure 6. ADD3 is required for BP process growth and proliferation, and effects of PALMD-
CaaX IUE on UL neurons. 
(A) List of top 10 PALMD interactors in IP from 12-13–wpc hNcx (triplicate analyses). Proteins 
are listed in descending order by their average number of unique peptides recovered. Green, 
adducins; blue, PALMD. 
(B) Immunoblots, using anti-PALMD (left) and anti-ADD3 (right) antibodies, of IPs from hNcx 
using control, anti-PALMD or anti-ADD3 antibodies. Arrowheads, PALMD (left), ADD3 (right). 
(C-F) hNcx tissue was electroporated ex vivo with mGFP together with plasmids encoding 
Cas9_T2A_GFP and gRNA targeting either LacZ (Control) or ADD3 (ADD3 KO), as indicated. 
(C) DAPI staining and IF for GFP, Ki67 and ADD3. Dashed lines, cell outline; arrowheads, 
presence of ADD3 along the PM of two non-electroporated progenitors in the ADD3 KO (right). 
(D) Distribution of the 5 bRG morphotypes, as shown schematically on the right. 
(E) Quantification of processes per single mBP. 
(F) Abventricular GFP+ (reflecting Cas9+) cells that are Ki67+, expressed as percentage of 
control. 
(G-K) Analyses of mNcx upon IUE with GFP and control or PALMD-CaaX as indicated. 
(G) DAPI staining and IF for GFP and Satb2. 
(H, I) Distribution of GFP+ cells (H) and Satb2+ GFP+ cells (I) across the CP layers. 
(J) Percentage of GFP+ cells in the CP that are Satb2+. 
(K) Thickness of CP layers V+VI and II+III+IV. 
(C, G) SOpS, StIs. Scale bars, 30 µm (G), 20 µm (C). 
(D-F, H-K) Mean of 5 (H-K) or 3 (D-F) experiments. Total number of cells scored: control 51 (D), 
39 (E); ADD3 KO 55 (D), 35 (E). Error bars, CI (D, E) or SD (F, H-K); **, P <0.01; *, P <0.05; n.s., 
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not statistically significant; two-way ANOVA with Bonferroni post-hoc tests (D, H, I), Student's 
t-test (E, F, J, K). 
See also Figure S6 and Table S2. 
 
Figure 7. The PALMD-CaaX–promoted increase in BP proliferation requires Itgb1. 
(A-C) Analyses of mNcx upon IUE with mGFP and control or PALMD-CaaX as indicated. 
(A) DAPI staining and IF for GFP and activated (act) Itb1. Boxes (30 x 30 μm), area shown at 
higher magnification in (A'). 
(B, C) Quantification of act Itgb1 (B), phospho-ERK (pERK, C) and phospho-Akt (pAk, C) 
immunoreactivity, determined as described in Methods. 
(D-G) Analyses of mNcx upon IUE with mGFP and PALMD-CaaX together with a plasmid 
encoding either scrambled shRNA (Control) or shRNA targeting Itgb1 as indicated. 
(D) DAPI staining and IF for GFP, Ki67 and PH3. Arrowheads, GFP+ basal mitoses. 
(E) Quantification of basal mGFP+ PH3+ mitoses. 
(F) Percentage of mGFP+ cells in SVZ+IZ that are Ki67+. 
(G) Quantification of processes per single mBP. 
(H, I) EM showing localization of Itgb1 (arrowheads) on the PM of processes of SVZ cells in 
mNcx (H) and hNcx (I). All images are oriented with the apical side facing left. 
(J) Model of PALMD-CaaX–mediated BP process growth and BP proliferation. 
(A, D, H, I) SOpS. StIs (A, D). Scale bars, 50 μm (A, D), 100 nm (H, I). 
(B, C, E-G) Mean of 3 (G), 4 (C, E, F), 7 (B) experiments. Total number of mBPs scored in (G): 
30 per condition. Error bars, SD (B, C, E, F) or CI (G); *, P <0.05; n.s., not statistically significant; 
Mann-Whitney U-test (B, C, E, F), Student's t-test (G). 
See also Figure S7. 
  




CONTACT FOR REAGENT AND RESOURCE SHARING 
Further information and requests for resources and reagents should be directed to and will 
be fulfilled by the Lead Contact, Wieland B. Huttner (huttner@mpi-cbg.de). 
 
EXPERIMENTAL MODEL AND SUBJECT DETAILS 
 
Experimental animals 
All experimental procedures were conducted in agreement with the German Animal Welfare 
Legislation after approval by the Landesdirektion Sachsen (licences: mouse TVV 5/2015, ferret 
TVV2/2015). Animals used for this study were kept in standardized hygienic conditions at the 
Biomedical Services Facility (BMS) of the MPI-CBG with free access to food and water. Animals 
were kept with the following light cycle (light/dark): 12 h / 12 h (mice) and 16 h / 8 h (ferrets). 
All experiments were performed in the dorsolateral telencephalon of mouse and ferret 
embryos, at a medial position along the rostro-caudal axis. The developmental time points of 
experimental procedures (E13.5 for mouse and E33 for ferret) correspond to a mid-
neurogenesis stage, when the production of UL neurons starts. The sex of embryos was not 
determined, as this is not likely to be of relevance for the results obtained in the present study. 
 
Mice 
Embryonic day E0.5 was set at noon of the day of vaginal plug identification. Mouse lines used 
were C57BL/6JOlaHsd and Palm1 KO line (Albrecht et al., 2013). C57BL/6JOlaHsd line was bred 
at the BMS of the MPI-CBG and the Palm1 KO line was bred at Max Planck Institute for 
Experimental Medicine and transported to MPI-CBG during the first week of pregnancy. 
 
Ferrets 
Timed-pregnant ferrets (Mustela putorius furo) were obtained from Marshall BioResources 
(NY, USA) or Euroferret (Copenhagen, Denmark) and housed at the BMS of MPI-CBG. 
Observed mating date was set to E0. 
 
Human tissue 
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Fetal human brain tissue was obtained from two sources. First, from the Klinik und Poliklinik 
für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Carl Gustav Carus of the 
Technische Universität Dresden, following elective pregnancy termination and informed 
written maternal consents, and with approval of the local University Hospital Ethical Review 
Committees. The age of fetuses ranged from 10-wpc to 12-wpc as assessed by ultrasound 
measurements of crown-rump length and other standard criteria of developmental stage 
determination. The second source was the Human Development Biology Resource (HDBR), 
with the fetal human material being provided by the Joint MRC/Wellcome Trust 
(MR/R006237/1) Human Developmental Biology Resource (www.hdbr.org). The HDBR 
provided tissue from fetuses aged 11-13–wpc. These developmental time points correspond 
to a mid-neurogenesis stage, when the production of UL neurons starts. Due to protection of 
data privacy, neither gender identity nor sex of the human fetuses from which Ncx tissue was 
obtained can be reported. Neither gender identity nor sex of the human fetuses is likely to be 
of relevance for the results obtained in the present study. The fetal hNcx tissue used in this 
study had not been subjected to  any additional procedures. No health disorders were 
reported for any of the fetal hNcx tissue samples used in this study. 
 
Fetal human brain tissue was dissected in PBS and used immediately for further manipulation 
or fixation when obtained from Dresden. When obtained from HDBR, tissue was dissected and 
shipped in Hibernate E media (Gibco A1247601). Upon arrival, the tissue was cultured in slice 





Human PALMD-CaaX– and PALMD-KKVI–encoding DNAs were amplified by PCR from a 12-wpc 
human brain cDNA library. The common forward primer, Palmd_SpHI_Fw, had an SpHI 
restriction site included upstream of the Kozak sequence. Both reverse primers 
(CAAX_BsrGI_Rev and KKVI_BsrGI_Rev) had a BsrGI restriction site included downstream of 
the stop codon. Subsequently, both PALMD isoforms were cloned into the pCAG vector using 
SpHI and BsrGI restriction enzymes. pCAG itself was generated from pCAG-GFP (a kind 
donation by Elly Tanaka and Stefania Tavano). PALMD-' was generated by site-directed 
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mutagenesis of the pCAG-PALMD-KKVI plasmid using the primers described in the Key 
Resources Table. The mutagenesis was performed using the QuikChange Lightning Site-
Directed Mutagenesis kit following the manufacturer’s instructions. The membrane GFP 
(mGFP) encoding plasmid used was pCAG-Lyn-GFP and was modified from the previously 
published pTα1-Lyn-GFP (Namba et al., 2014). Knock-down of Itgb1 in mNcx was performed 
using the pSuper RNAi system. The control vector, pSuper-Scrambled shRNA (kind gift by K. 
Kaibuchi), was modified to generate the pSuper-itgb1 shRNA vector with the 
AAGGGCCAACTTGTGAGACAT target sequence. Other commercial vectors used are listed in 
the Key Resources Table. 
 
All DNA was purified using the QIAquick PCR Purification Kit (QIAGEN), eluted in 5 μl of distilled 
water and used to transform competent bacteria. All DNA plasmids were extracted and 
purified using the EndoFree Plasmid Maxi kit (QIAGEN) following the manufacturer’s 
instructions. 
 
CRISPR/Cas9 strategy and in vitro testing 
CRISPR/Cas9 approach used for obtaining PALMD and ADD3 KOs ex vivo in hNcx was similar 
to the approach established previously in the mNcx in vivo (Kalebic et al., 2016). For controls, 
a previously published gRNA targeting LacZ was used (Kalebic et al., 2016). For disruption of 
PALMD, the genomic sequence of human PALMD was analyzed for CRISPR/Cas9 target sites 
by Geneious 11 software (Biomatters), and 7 gRNAs (cr1–cr7, Figure S5B, C) were selected. 
Cr1–cr4 had a forward orientation (identical in sequence to the DNA sense strand and not 
complementary to the mRNA sequence), and cr5–cr7 had a reverse orientation. gRNAs were 
produced by in vitro transcription from a PCR product as previously described (Kalebic et al., 
2016). Recombinant Cas9 protein (ToolGen) from Streptococcus pyogenes was used. 
 
Individual gRNAs were first tested in vitro using recombinant Cas9 protein and the PCR 
products of the Palmd locus. Three different PCR templates were made (Figure S5). PCR1 was 
used as the template for cr1, which guides cutting in intron 1, PCR2 was used for cr2 (cutting 
in exon 4) and PCR3 was used for the remaining gRNAs, all of which guide cutting in exon 7. 
Cutting by Cas9 of the target sequence in vitro was performed as previously described (Kalebic 
et al., 2016). Briefly, an in vitro reaction contained 12 ng/μl of the PCR product, 50 ng/μl of 
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recombinant Cas9 protein, and 35 ng/μl of the indicated in vitro transcribed gRNAs, in a total 
volume of 10 μl. Reactions were carried out at 37°C for 1 h. Samples were then treated with 
4 μg of RNAse (Qiagen) for 15 min at 37°C, followed by addition of 2.5 μg of proteinase K 
(Merck) and further incubation for 10 min at 55°C. After 5 min at room temperature, samples 
received 1 μl of STOP solution (30% glycerol, 1.2% SDS, 250 mM EDTA pH 8.0; ToolGen) and 
were incubated for a further 15 min at 37°C, followed by analysis on a 1% agarose gel. 
 
Based on the results of the in vitro testing, three gRNAs were selected for the ex vivo 
experiments. Cr1 was selected because it was able to guide Cas9-mediated cutting of the 
template and it was located most 5’ within the Palmd gene; such a location has been shown 
to increase the probability of obtaining disruption of gene expression (Kalebic et al., 2016). 
Cr2 and cr3 were selected since they had the greatest efficiency of guiding the cutting of the 
PCR product, as revealed by the in vitro reaction (Figure S5C). 
 
The three selected gRNAs were obtained from DNA 2.0, cloned into pD1321-AP plasmids 
under the control of the human U6 promoter. The same plasmid contained the Cas9 gene 
under the CAG promoter, followed by sequences encoding the proteolytic self-cleaving 2A 
peptide from Thosea asigna virus (T2A) and Paprika RFP, which was used as an indicator of 
Cas9 expression. Cas9 was flanked with two nuclear localization signals (5’ and 3’, (Kalebic et 
al., 2016)). 
 
For the ADD3 KO, plasmids encoding three different gRNAs were obtained from Santa Cruz 
(adducin γ CRISPR/Cas9 KO plasmid (h); sc-417366). The plasmid design was similar to the one 
used for the PALMD KO. Briefly, gRNAs were under the control of the human U6 promoter 
and Cas9 under the CBh promoter. Cas9 was followed by T2A peptide and GFP. 
 
In vivo experiments in mouse 
IUEs were performed as previously described (Kalebic et al., 2016). Briefly, pregnant mice with 
E13.5 embryos were anesthetized with isofluorane, first in a narcosis box (with 4% isoflurane) 
and then transferred to the operation platform, with their nose being connected to 2.5% 
isoflurane. Subsequently the animals were injected subcutaneously with the analgesic (0.1ml, 
Metamizol, 200mg/kg). The peritoneal cavity was then surgically opened and the uterus 
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exposed. Embryos were then injected intraventricularly with a solution containing 0.1% Fast 
Green (Sigma) in sterile PBS, 2 μg/μl of one of the CAG plasmids (empty vector, PALMD-CaaX, 
PALMD-KKVI, PALMD-') and 1 μg/μl of the mGFP vector. All electroporations were performed 
with six 50-msec pulses of 28-33 V at 1 sec intervals. After surgery mice received Metamizol 
for two days via drinking water (1.33 mg/ml). Mice were sacrificed by cervical dislocation and 
embryos were harvested 16 h or 48 h post-electroporation, and the embryonic brains were 
dissected and PFA-fixed (see below) for the IF analyses or transferred into HERO culture (see 
below). 
 
For the cell cycle re-entry experiments, a single pulse of EdU was injected at E14.5, i.e. 24 h 
after the IUE, and the animals were sacrificed 24 h later, as previously described (Wong et al., 
2015). The cell cycle re-entry analysis was performed by quantifying the proportion of Ki67+ 
EdU+ GFP+ cells out of all EdU+ GFP+ cells. Considering that (i) EdU was likely incorporated 
only during the first 5 h after injection and (ii) the length of the S + G2 + M phase is less than 
11 h at E14 (Wong et al., 2015), this type of analysis was suitable for determining whether the 
resulting daughter cells were still cycling or not. 
 
In vivo experiments in ferret 
IUE of ferrets was performed as originally established by Hiroshi Kawasaki with the 
modifications described below (Kawasaki et al., 2012). Pregnant ferrets (with embryos at E33) 
were kept fasted for at least 3 h before the surgery and placed in the narcosis box with 4% 
isoflurane. Subsequently they were positioned on the operation table and attached to the 
narcosis mask with 3% isoflurane and injected subcutaneously with analgesic (0.1 ml 
Metamizol, 50 mg/kg), antibiotic (0.13 ml Synulox, 20 mg/kg or 0.1 ml amoxicillin, 10 mg/kg) 
and glucose (10 ml 5% glucose solution). The ferret bellies were then shaved, sterilized with 
iodide and surgically opened. The uterus was exposed and embryos were then injected 
intraventricularly with a solution containing 0.1% Fast Green (Sigma) in sterile PBS, 2.5 μg/μl 
of one of the CAG plasmids (empty vector, PALMD-CaaX) and 1.25 μg/μl of the mGFP vector. 
Electroporations were performed with six 50-msec pulses of 100 V at 1 sec intervals. 
Subsequently, the uterus was placed back in the peritoneal cavity, the muscle layer with the 
peritoneum was sutured using a 4-0 suture, after which the skin was sutured intracutaneously 
using 4-0 suture. Animals were carefully monitored until they woke up and then underwent 
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postoperative care for the following 3 days (2 x daily 10 mg/kg amoxicillin, 3 x daily 25 mg/kg 
Metamizol). 
 
Two days after electroporation embryos were harvested. This occurred either after sacrificing 
the mother or by performing a second surgery. When the pregnant ferrets were sacrificed the 
protocol was as follows: 4 mg/kg Xylazin + 40 mg/kg Ketamin (0.2 ml Xylazin and 0.4 ml 
Ketamin) subcutaneously. After the embryos were removed, the ferrets were euthanized by 
an intracardial injection of 0.3 ml/animal T61. 
 
When the pregnant ferrets were not sacrificed, they underwent another surgery that followed 
the same pre-operative care, anesthesia and analgesia as the first surgery. The sutures from 
the first operation were removed and the uterus exposed, after which the embryos were 
removed by a caesarian section. Subsequently a complete hysterectomy was performed, after 
which the muscle layer with peritoneum and skin were sutured and the animal underwent the 
same post-operative care as after the first surgery. Animals were kept at the BMS of the MPI-
CBG for at least two weeks after the second surgery after which they were donated for 
adoption. Embryonic brains were dissected and PFA-fixed for the IF analyses. 
 
Ex vivo experiments on hNcx 
Culture of hNcx tissue was done in slice culture medium (SCM): 84 ml of Neurobasal medium 
(Gibco, 21103049) supplemented with 10 ml of KnockOut Serum Replacement (Gibco, 
10828028), 1 ml glutamine (2 mM), 1 ml Penstrep (100x), 1 ml N-2 (100x) (Gibco, 17502048), 
2 ml B-27 (50x) (Gibco, 17504044) and 1 ml of 1 M HEPES-NaOH, pH 7.2, to yield a final volume 
of 100 ml. 
 
For ex vivo electroporation, the hNcx tissue was placed in an electroporation chamber filled 
with sterile PBS. Tissue was positioned parallel to the electrodes so that the apical surface was 
facing the negative and the basal surface the positive electrode. The solution containing 0.1% 
Fast Green (Sigma) in sterile PBS along with the plasmids was administered adjacent to the 
apical surface of the tissue. Considering that the electroporated areas were difficult to identity 
when using only the plasmid encoding mGFP, we always administered a combination of 
plasmids encoding mGFP and soluble GFP to facilitate visualization. When only the two GFP 
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plasmids were used, 2 μg/μl of each plasmid was used. For the CRISPR/Cas9–mediated 
disruption of PALMD, 1 μg/μl of mGFP plasmid, 1 μg/μl of soluble GFP plasmid and 3 μg/μl of 
plasmids encoding Cas9 and gRNAs were used (control 3 μg/μl of gLacZ plasmid; PALMD KO 1 
μg/μl of each of the three gPalmd plasmids). Electroporations were performed with ten 50-
msec pulses of 36 V at 1 sec intervals. Subsequently, the tissue was washed in PBS, placed into 
a rotating flask with 1.5 ml SCM, and incubated at 37°C for 3-4 days in a humidified 
atmosphere of 40% O2 / 5% CO2 / 55% N2, before being fixed. 
 
For the 2-bromopalmitate (2BrPal) treatment, 2BrPal (Sigma, 238422) was dissolved in DMSO 
and a 100 mM stock solution was stored at –20°C. hNcx tissue was electroporated with 
(m)GFP-encoding plasmid(s) and kept in culture for one day, after which it was treated for 2 h 
at 37°C with 100 µM final concentration of 2BrPal in SCM or 0.1% DMSO as control. 
Subsequently, the tissue was transferred to a new flask with DMSO-free SCM and incubated 
for an additional 2 days at 37°C, before being fixed. 
 
For ITGB1-blocking antibody treatment, P5D2 blocking antibody was used (Loulier et al., 
2009). hNcx tissue was kept in culture for one day, after which it was incubated with the P5D2 
antibody diluted 1:100 for 24 h in SCM at 37°C, before being fixed. 
 
Ex vivo experiments on mouse hemispheres 
Mouse embryonic brains were electroporated at E13.5 and isolated 16 h later. Meninges were 
surgically removed and electroporated hemispheres were placed in the hemisphere rotation 
(HERO) culture. The HERO culture conditions were as previously described (Schenk et al., 
2009). Upon dissection, hemispheres were placed in rotating flasks with 1.5 ml mouse SCM 
(mSCM), which had the identical composition as SCM described above except that 10 ml of 
the KnockOut Serum Replacement were replaced by the same amount of rat serum. 
Hemispheres were kept in mSCM for 2 h at 37°C to recover. Subsequently, the hemispheres 
were treated for 24 h at 37°C either with 20 µM final concentration of 2BrPal in SCM or with 
DMSO as control, before being fixed. 
 
Transfection of cells in culture 
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To examine the subcellular localization of PALMD proteins we used EpH4-Ev, a mouse 
epithelial cell line that does not express detectable levels of Palmd protein. EpH4-Ev cells were 
seeded into 12-well plates at a density of 200,000 cells / well and transfected using 
Lipofectamine 2000 following the manufacturer’s instructions. Cells in each well were 
transfected with 1 μg mGFP plasmid along with 4 μg of one of the pCAG plasmids (PALMD-
Caax, PALMD-KKVI, PALMD-', or empty vector). One day after transfection, cells were re-




DiI labeling of the hNcx tissue (12-wpc) was performed as previously described (Florio et al., 
2015). Brielfy, a DiI working solution was prepared as previously described (Florio et al., 2015) 
and applied on the basal surface of the hNcx tissue by means of mouth-controlled pipette-tip. 
The dye was applied sparsely to facilitate the visualization of individual cells. After a single 
passage of DiI application, the tissue was washed 3 times with PBS and incubated in SCM (see 
above) for 4 h at 37qC. Subsequently, the tissue was PFA-fixed for 24 h at 4qC. After fixation 
the tissue was sectioned on a vibratome and 100-μm thick sections were stained with DAPI 
and mounted on microscopy slides with Mowiol. 
 
Sectioning 
Briefly, the tissue was fixed in 4% paraformaldehyde in 120 mM phosphate buffer pH 7.4 
(referred to as PFA fixative) for 24 h (mNcx and hNcx tissue) or 48 h (fNcx) at 4qC. 
Subsequently, fixed tissue was sectioned on either a cryostat or vibratome. Cryosections were 
20-50 μm thick and were mainly used for quantifications of nuclear markers. For cell tracking 
experiments, thick vibratome sections were used. Thickness of sections was as follows: 100-
µm thick sections, all DiI experiments (Figure 1B, S1D-G), IF for Hopx/Sox2 in mNcx (Figure 
2SH-J), all the experiments ex vivo with 2BrPal treatment (Figure 5A-G); 70-100–µm thick 
sections, all the mGFP tracking experiments in fNcx and hNcx and most of the experiments in 
E15.5 mNcx (Figure 2, S2A-F, O-P, Figure 5H-L, Figure 6C-E, Figure S6A-C, Figure S7D-G, most 
of experiments in Figure 3), all the HOPX/SOX2, IFs for HOPX/ANLN and BLBP/SOX2 in hNcx 
(Figure 1A, S1A-C, H-H", S2G), IF for PhVim in mNcx (Figure S2K-N); 50-µm thick sections, few 
mGFP tracking experiments in E15.5 mNcx (in Figure 3), IF for OLIG2 in hNcx (Figure 1I-N). 




IF was performed as previously described (Florio et al., 2015; Kalebic et al., 2016). When 
necessary, an antigen retrieval was performed (1 h incubation with 10 mM citrate buffer pH 
6.0 at 70qC in a water bath or oven for mouse and ferret; 30 min with the same buffer for 
human tissue), followed by 3 washings with PBS, permeabilization for 30 min in 0.3% Triton X-
100 at room temperature, quenching for 30 min in 0.1 M glycine in PBS at room temperature 
and blocking for 30 min in blocking solution (0.2% gelatin, 300 mM NaCl, 0.3% Triton X-100 in 
PBS). Primary antibodies were incubated in blocking buffer for 12 h – 3 days, at 4qC, depending 
on the antibody used. Subsequently the sections were washed 3 times in blocking solution, 
incubated with secondary antibodies (1:500 to 1:1000) and DAPI (Sigma) in blocking solution 
for 1-2 h at room temperature, and washed again 3 times in blocking solution before being 
mounted on microscopy slides with Mowiol. 
 
EpH4 cells in culture were washed twice with PBS and fixed in the same fixative as the tissue 
for 5 min at room temperature. Afterwards IF was performed as described above for tissue. 
 
Primary antibodies used for IF were all diluted 1:200 except for the following antibodies: anti-
GFP and rabbit anti-RFP (1:1000), anti-pan-cadherin and rat anti-RFP (1:500), anti-PH3 (1:300), 
anti-Palmd (1:50). The PALMD antibody used was raised against amino acids 40-69 of human 
PALMD. This sequence is identical for PALMD-CaaX and PALMD-KKVI and therefore this 
antibody cannot be used to distinguish the two isoforms. The ADD3 antibody used was raised 
against amino acids 571-630 of human ADD3. Of these 60 amino acids, 55 are conserved in 
ferret and 47 in mouse ADD3. 
 
Image acquisition 
Most of the fluorescent images were acquired using a Zeiss LSM 880 upright single photon 
point scanning confocal system, and only few images were acquired using a Zeiss LSM 510 
Duoscan laser-scanning confocal microscope. Images were taken as either 1-μm optical 
sections with a 40x objective or 2-μm optical sections with a 20x objective. When the images 
were taken as tile scans, the stitching of the tiles was performed using the ZEN software and 
the images are referred to in the figure legends as "stitched images" (StIs). The images are 
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presented either as single optical sections (referred to in the figure legends as "SOpS") or as 
maximum intensity projections (referred to in the figure legends as "MIPs"). The images were 
analyzed with ImageJ and processed with either ImageJ or Imaris 8 (BitPlane). The orthogonal 
projections and movies with the 3D visualization of cells were made using Imaris 8. 
 
Electron microscopy 
Electron microscopy was performed as described previously (Wilsch-Bräuninger et al., 2012), 
with the addition of antigen retrieval (for Palmd EM only, 30-min incubation with 10 mM 
citrate buffer pH 6.0 at 95qC in an incubator) prior to blocking. The primary antibodies against 
Palmd and Itgb1 (P5D2) were used at a 1:5-1:10 dilution and the signal was detected either by 
Protein A conjugated to 10 nm gold particles at a 1:50 dilution (for Palmd), or by a secondary 
antibody against mouse IgG conjugated to 10 nm gold particles at a 1:30 dilution (for Itgb1). 
 
Immunoprecipitation and immunoblotting 
For co-immunoprecipitation, all steps were performed at 4°C unless indicated otherwise. Affi-
Prep® Protein A Resin beads (Bio-Rad, 1560006) were washed 3 times with 1 ml PBST (PBS, 
0.04% Triton X-100) and incubated in 1ml PBST with 50 μg per 50 μl settled beads of either α-
PALMD antibody (Abcam, ab129388) or α-ADD3 antibody (Santa Cruz, sc-74474) for 1 h at 
room temperature. Antibody-bound beads were then washed 3 times with PBST and lysis 
buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 1 mM EDTA, 0.1% SDS, 1% NP-40, Merck 
cOmplete™ Protease Inhibitor Cocktail) and stored on ice until use. Control beads were 
prepared in the same way using rabbit serum IgG fraction (Sigma-Aldrich, I5006). 
Embryonic/fetal brain tissue (E15.5 mouse, E37 ferret, 12-13–wpc human) was homogenized 
in 5 ml of lysis buffer on ice using a glass homogenizer (final protein concentration in the 
lysates: mouse 5 mg/ml, ferret 4 mg/ml, human 1-5 mg/ml). The lysates were centrifuged for 
40 min, 10,000 g at 4°C, and 2 ml of supernatant per 50 µl of settled beads was added to 
experimental (α-PALMD or α-ADD3 bound) and control beads. In any given experiment, the 
same amount of protein was added to the three types of beads. Supernatants were incubated 
with the beads for 2 h in a cold room under rotation, which were then washed 3 times with 
lysis buffer. Bound proteins were eluted with sample buffer (ThermoFisher Scientific 
NuPAGE™ LDS Sample buffer, NP0007; 50 mM DTT), and samples were run on SDS-PAGE 
(ThermoFisher Scientific NuPAGE™ 4-12% Bis-Tris Protein Gel 1.0 mm, 10-well NP0321; 
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NuPAGE™ MES SDS Running Buffer NP0002). Gels were then processed for immunoblotting 
or MS. 
 
For immunoblot analysis, gels were transferred for 2 h at 30 V in 10% methanol NuPAGE™ 
Transfer Buffer (ThermoFisher Scientific, NP0006). Membranes (Merck Immobilon®-P PVDF 
Membrane, IPVH00010) were blocked with 5% skim milk in PBST and incubated overnight with 
primary antibody (α-PALMD 1:1000 or α-ADD3 1:1000). Membranes were washed three times 
with PBST, incubated with secondary antibody (Peroxidase IgG Fraction Monoclonal Mouse 
Anti-Rabbit IgG, Light Chain Specific or Peroxidase AffiniPure Donkey Anti-Mouse IgG (H+L) 
1:10,000; Jackson ImmunoResearch) for 1 h at room temperature, washed three times with 
PBST and developed for 5 min with SuperSignal™ West Dura Extended Duration Substrate 
(ThermoFisher Scientific, 34075). Times of exposure to X-ray film were varied for best visibility. 
Images were acquired using transmitted light. 
 
Mass spectrometry (MS) 
For MS, gels were incubated in Coomassie staining solution (50% methanol, 10% acetic acid, 
0.2% CBB R-250) for 30 min at room temperature followed by washing in de-staining solution 
(50% methanol, 2% acetic acid). Gels were then transferred to water and subjected to GeLC 
MSMS analysis. 
 
Coomassie-stained gel lanes were cut into 10 pieces per lane, each of which was then 
processed individually. Each gel piece was cut into 1x1 mm cubes, incubated with 10 mM DTT 
and 55 mM iodacetamide in 10 mM ammonium bicarbonate, and dehydrated with 
acetonitrile. The gel pieces were then rehydrated in 10 mM ammonium bicarbonate 
containing 10% acetonitrile and 12 ng/µl trypsin (modified, sequencing grade, Promega, 
Mannheim) and subjected to overnight in-gel digestion at 37°C. The resulting peptide mixtures 
were extracted twice with exchange of 5% formic acid and 100% acetonitrile, the extracts 
pooled together and dried down. The dry residue containing the peptides was dissolved in 20 
µl of 5% formic acid, and 5 µl were taken for LCMSMS analysis. This analysis was performed 
on a nano-UPLC Ultimate 3000 interfaced on-line to a Velos LTQ Orbitrap hybrid mass 
spectrometer (both Thermo Fischer Scientific, Bremen). The UPLC system was equipped with 
Acclam PepMaptm 100 75 µm x 2 cm trapping column and 75 µm x 50 cm separating column 
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packed with 3 µm diameter C18 particles (Thermo Fischer Scientific, Bremen), which was 
heated to 50°C. Peptides recovered from each gel piece were separated using a 180 min linear 
gradient 0 to 35 % of solvent B (0.1% formic acid in acetonitrile) in solvent A (0.1% formic acid 
in water) followed by step increase to 100% solvent B for 15 minutes. Velos instrument was 
operating in CID mode where 1 MS scan (R=60000) was followed by MSMS acquired on top 
20 most abundant ions. Normalized collision energy was set on 35 and dynamic exclusion time 
on 25 s. The lock-mass function was set to recalibrate MS1 scans using the background ion 
(Si(CH3)2O)6 at m/z 445.12. Spectra acquired for pieces from the same gel lane were converted 
into .mgf format, merged into a single file and searched against human, mouse or ferret 
sequences in the UniProt database (January 2018) using MASCOT software (version 2.2.04, 
Matrix Sciences Ltd, London, UK). Mass tolerance was set on 5 ppm and 0.5 Da for precursor 
and fragment ions respectively; enzyme specificity – trypsin; number of miscleavages was set 
on two; variable modification – cysteine carbamidomethyl and propionamide, methionine 
oxidation, protein N-terminal acetyl. The results of the database searches were evaluated by 
Scaffold software v.4.7.5 (Proteome Software, Portland). Protein hits were accepted if 
matched with one peptide under 90% and 95% probability thresholds for peptides and 
proteins, respectively. Proteins and spectra False Discovery Rates (FDR, function of the 
Scaffold software) were calculated below 1%. 
 
Human PALMD immunoprecipitation and subsequent MS analysis were performed in 
triplicates. Of the 603 proteins identified in total by MS in the sum of the three PALMD and 
the three control immunoprecipitates, 21 were found exclusively in all three PALMD 
immunoprecipitates but not in any of the control immunoprecipitates. This list of 21 
interactors also contained the bait, PALMD itself. Among the top five interactors on this list 
(Table S2), three belonged to the adducin family of proteins (ADD1, ADD2, ADD3). For this 
reason, we examined the mRNA expression levels of the three members of the adducin family 
in the previously published transcriptome datasets (Fietz et al., 2012; Florio et al., 2015) and, 
based on the similarity of the ADD3 mRNA expression pattern (Figure S6D) with that of PALMD 
(Figure S3A), identified ADD3 as the top candidate to be a PALMD interactor. 
Immunoprecipitation of ferret and mouse Palmd followed by MS analysis was performed in 
the same way, but only once each. ADD3 was found in the ferret, but not the mouse, Palmd 
immunoprecipitate (Table S2). 
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QUANTIFICATION AND STATISTICAL ANALYSIS 
 
Tracking cell outlines 
To analyze the morphology of BPs in a quantitative manner, we developed a semi-manual 
workflow named Progenitors Process Analysis (PPA) software. Images used for this workflow 
were acquired on a confocal microscope with a 40x objective as ≈50-100–μm thick stacks of 
1-μm thick optical sections. Individual cells were first annotated manually with Fiji plugin 
trakEM2 and exported as 2D masks for further analysis. Each cell was processed to create a 
mask of the cell body and a skeleton of the processes. The cell body mask was then combined 
with the processes skeleton, constituting a simplified representation of the cell that could be 
used for the analysis of its morphology. If necessary the cell body mask could be corrected 
manually during the process. In this representation, each process is a branching tree. It is in 
contact with the cell body at a single position, may or may not divide into multiple branches 
defining one or more extremities. For each BP the number of processes, the total number of 
process extremities, the branching index (ratio of all process extremities to the primary 
processes count) and the cell body (soma) radius were measured. Additionally, a Sholl analysis 
was performed, which consisted of counting the number of branches intersecting circles of 
either 2r, 3r or 4r, with r being the radius of the cell body and the circle center being in the 
middle of the cell body. For each process, we also measured its length and tortuosity. Finally, 
for each analyzed cell, an image allowing the visual inspection of the cell body and the 
detected processes was generated. This entire workflow was implemented as a script for the 
freely available Fiji software. The script was tested with the Fiji version: (Fiji is just ImageJ) 
ImageJ 2.0.0-rc-61/1.51n. The source code of the script and its helper library are available on 
an online repository (git platform of MPI-CBG, https://git.mpi-cbg.de/bioimage-
informatics/Progenitors_Processes_Analysis). Additional details on the installation, usage and 
implementation of the workflow can be found on that repository. 
 
Tracking of DiI-labeled bRG basal processes (Figure S1F) was performed starting from the basal 
side and stopping at the cell body in the SVZ. The tracked processes were analyzed with 
respect to whether they contained a splitting site or not. Splitting sites in the basal-most 50 
µm were excluded as those likely accounted for basal end-foot branching and not radial 
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process bifurcation. As DiI was applied on the basal surface, only bRG-b, bRG-ab and the 
morphotypes identified here (bRG-bbf and bRG-abbf) could be traced. 
 
Identification of PALMD 
To identify genes that potentially regulate BP morphology in hNcx, we used a published 
transcriptome dataset of mouse and human Ncx zones (GSE38805) (Fietz et al., 2012). As 
summarized in Figure 3A, of the 13.719 genes that were found to be expressed in fetal human 
OSVZ and ISVZ (FPKM >1), we focused our analysis on those genes that exhibited an at least 
2-fold higher level of expression in the OSVZ and ISVZ compared to the VZ and CP, which 
yielded 250 genes. Among these 250 genes, we focused our attention on those genes that 
exhibited and at least 10-fold increase in FPKM value from the VZ to the OSVZ and from the 
VZ to the ISVZ, which yielded 25 genes (Table S1). Of these 25 genes, 7 were potentially related 
to cell morphology by GO term analysis (Table S1). The top candidate among these 7 potential 
morpho-regulatory genes that exhibited the highest fold change between VZ and OSVZ/ISVZ 
(of all 25 genes) was PALMD (96-fold increase between VZ and OSVZ and 56-fold increase 
between VZ and ISVZ). In the transcriptome of mNcx (Fietz et al., 2012), Palmd was also found 
to be enriched in the SVZ compared to VZ and CP, but the fold increase between VZ and SVZ 
was only 2. This suggested that (i) Palmd could potentially be a general regulator of BP 
morphology across different mammalian species, and (ii) that Palmd exhibits evolutionary 
different expression levels, which was in line with our findings on the evolutionary increase in 
the number of BP processes and BP morphotypes. For the above-mentioned reasons, we 
selected PALMD as our candidate to manipulate BP morphology. 
 
The data of gene expression in various neocortical cell types isolated from mNcx and hNcx are 
from the previously published datasets of mouse and human Ncx cells (GSE65000) (Florio et 
al., 2015). To determine the expression levels of individual PALMD isoforms, the Kallisto 
probabilistic algorithm was used. The age of the fetuses used for the transcriptome study of 
the hNcx ranged from 13-wpc to 16-wpc (Fietz et al., 2012) and from 12-wpc to 13-wpc (Florio 
et al., 2015). All these fetal stages are comparable to the stages we used for our various 
analyses in hNcx (11-wpc to 16-wpc). 
 
Cell counting 
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All cell counts were performed in standardized microscopic fields using Fiji, processed using 
Excel (Microsoft), and results were plotted using Prism (GraphPad Software). For each 
condition, data (typically at least 3 microscopic fields) from one experiment (see definition 
below) were pooled, and the mean of the indicated number of experiments was calculated. 
Whenever possible the quantifications were done blindly. To identify BPs we uniformly used 
the marker shown in the panel(s) preceding the respective quantification of morphology, or 
markers indicated along with the quantification of morphology. For mGFP-electroporated BPs, 
PCNA (Figure 2D-G; Figure S2E; Figure 3K; Figure S3O, Figure 5F, I-K; Figure S5A; Figure S5I, J) 
or Ki67 (Figure 3G, H; Figure S3I-L; Figure 5C; Figure 6D, E; Figure S6B; Figure 7G) were used 
as markers. For non-electroporated BPs, Hopx+Sox2 were used as markers (Figure S1H, L, M; 
Figure S2G, J). For the mGFP-electroporated bRG analyzed in Figure 3L and Figure S3P, in 
addition to PCNA+ cells with radial morphology, Pax6 was used as marker. For mitotic BPs, 
PH3 (Figure 3R, S) and PhVim (Figure S2M, N, Figure 3O) were used as markers. DAPI staining 
was used to delineate the border between layer III and layer IV and the border between layer 
IV and layer V in the mouse E18.5 CP (Figure 6G-K). 
 
Quantification of IF intensity 
All quantifications of IF intensity were done blindly. The quantifications of the IF intensity upon 
PALMD and ADD3 KOs were done focusing only on those RFP+ (for PALMD KO) or GFP+ (for 
ADD3 KO) cells that were not in direct contact with other RFP+/GFP+ cells. The cell perimeter 
was outlined using the RFP/GFP channel, as this channel reflected the expression of a protein 
which contained no specific localization signal and which marked the entire cell body along 
with the clearly identifiable processes. Subsequently, by using the DAPI channel, a 
confirmation that the outlined area contained only a single nucleus was obtained. After 
switching to the PALMD/ADD3 channel, a measurement of the IF intensity within the outlined 
area was performed. Measuring of the PALMD/ADD3 IF intensity was performed only for 
those outlined areas that met the above-mentioned criteria (no overlap with other cells, 
presence of a single nucleus). Upon subtraction of the background signal, the average IF 
intensity level of the control conditions was set to 100%, and all the IF intensity levels of the 
KO conditions were expressed relative to this. 
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The quantifications of the Itgb1, active Itgb1, pERK and pAkt IF intensities upon PALMD-CaaX 
expression and the quantification of Itgb1 IF intensity upon combined PALMD-CaaX expression 
and Itgb1 KD were done as follows. Inspecting the GFP channel, which reflected the location 
of the electroporated area, a 50 µm x 50 µm region of interest (ROI) was selected in the SVZ. 
Subsequently, by using the DAPI channel, a confirmation that the selected ROI was located in 
the SVZ was obtained. Switching to the Itgb1/pERK/pAkt channel, the level of IF intensity was 
measured within the ROI. A total of 3-5 different ROIs in the electroporated area were selected 
for each section, and the mean was calculated. Subsequently, 1-2 ROIs of the same dimensions 
were selected in the SVZ outside the electroporated area of the same histological section. In 
case of small-area electroporations, this was done by selecting ROIs in the same hemisphere. 
In case of large electroporations that were spanning the majority of the hemisphere, an 
equivalent position was selected in the contralateral hemisphere. The level of IF intensity of 
the electroporated SVZ was expressed relative to the level of this intensity from the non-
electroporated area of the same histological section. 
 
Statistical analyses 
Sample sizes are reported in each figure legend, where the term "one experiment" refers to 
one embryo coming from an independent litter for analysis of mNcx and fNcx and to one 
individual hNcx tissue sample for analysis of hNcx. All IUE experiments were performed in as 
many litters as indicated in each figure legend with the term "experiment". From each litter a 
single control and experimental (usually PALMD-CaaX expression) embryo were used for 
further analysis. No litters and hNcx tissue samples were excluded from the statistical analysis. 
 
All statistics analyses were conducted using Prism (GraphPad Software). We used parametric 
statistics for normally distributed data (determined by Shapiro-Wilk or D'Agostino-Pearson 
omnibus normality tests with alpha level of 0.05) and non-parametric tests otherwise. Tests 
used were two-way ANOVA with Bonferroni post-hoc test, one-way ANOVA with Dunnett's 
multiple comparisons test, Student's t-test and Mann-Whitney U-test. For each quantification, 
the statistical test and P value are indicated in the figure legend. For the main figures, when 
the comparisons between different categories were made, P values of the post-hoc test are 
indicated as follows: Figure 2F, bRG-b (mouse vs. ferret, P =0.0009; mouse vs. human, P 
<0.0001; ferret vs. human, P =0.0281); Figure 2F, bRG morphotypes with two or more 
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processes (bRG-ab+bRG-(a)bbf) vs. bRG with a single process (bRG-b+bRG-a) (human vs. 
mouse, P<0.0001; ferret vs. mouse, P=0.0078); Figure 3J, bRG-b (control vs. PALMD-CaaX 
P=0.039); Figure 5I, bRG-b (control vs. PALMD KO, P=0.0016); Figure 6D, bRG-b (control vs. 
ADD3 KO, P=0.0041); Figure 6H, layers II+III (control vs. PALMD-CaaX, P=0.0101); Figure 6H, 
layers V+VI (control vs. PALMD-CaaX, P=0.0017); Figure 6I, layers V+VI (control vs. PALMD-
CaaX, P=0.0068). For the supplemental figures the P values of the post-hoc test are given in 
the respective figure legends. 
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Supplemental movie S1 Related to Figure 1. 3D representation of a bRG-abbf in hNcx 
revealed by DiI. 
 
Supplemental movie S2 Related to Figures 1 and S1. 3D representation of a bRG-ab and bRG-
b in hNcx revealed by DiI. 
 
Supplemental movie S3 Related to Figures 1 and S1. 3D representation of a bRG-bbf in hNcx 
revealed by DiI. 
 
Supplemental movie S4 Related to Figure 2. 3D representation of a bRG-bbf in hNcx revealed 
by mGFP fluorescence, with its cell mask indicated subsequently. 
KEY RESOURCES TABLE 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
Goat anti-Sox2 R+D Systems AF2018, RRID:AB_355110 
Mouse anti-Hopx Santa Cruz Biotech Sc-398703, RRID:AB_2687966 
Rabbit anti-Hopx (FL-73) Santa Cruz Biotech Sc-30216, RRID:AB_2120833 
Rabbit anti-Blbp LifeSpanBioScience LS-C30565, RRID:AB_2100467 
Chicken anti-GFP Abcam ab13970, RRID:AB_300798 
Rat anti-RFP ChromoTek Cat#5F8 
Rabbit anti-RFP Rockland antibodies 600-401-379, RRID:AB_2209751 
Goat anti-Anillin Abcam ab5910, RRID:AB_2058292 
Rabbit anti-Olig2 Millipore ab9610, RRID:AB_570666 
Goat anti-GFP MPI-CBG N.A. 
Rabbit anti-Ki67 Abcam ab15580, RRID:AB_443209 
Rabbit anti-Pax6 Covance PRB-278P, RRID:AB_291612 
Mouse anti-PCNA Millipore CBL407, RRID:AB_93501 
Rabbit anti-Palmd Abcam ab129388, RRID:AB_11145499 
Mouse anti-PanCDH, clone CH-19 Sigma C 1821, RRID:AB_476826 
Mouse anti-PhVim Abcam ab22651, RRID:AB_447222 
Rat anti-PH3 Abcam ab10543, RRID:AB_2295065 
Mouse anti-ADD3 Santa Cruz sc74474, RRID:AB_1118719 
Mouse anti-Satb2 Abcam ab51502, RRID:AB_882455 
Rat anti-CD29 E1 integrin (active), clone 9EG7 BD Pharmigen 550531, RRID:AB_393729 
Mouse anti-E1 integrin (blocking antibody), P5D2 Abcam ab24693, RRID:AB_448230 
Phospho-p44/42 MAPK (Erk1/2) (Tyr 202/Tyr204) Cell Signaling Cat# 9106, RRID:AB_331768 
Mouse anti-AKT pS473 Rockland antibodies 200-301-268S, RRID:AB_2224884 
Goat anti-Chicken Alexa Fluor 488 ThermoFisher Scientific A11039, RRID:AB_142924 
Donkey anti-Goat Alexa Fluor 488 ThermoFisher Scientific A11055, RRID:AB_2534102 
Donkey anti-Goat Alexa Fluor 555 ThermoFisher Scientific A21432, RRID:AB_2535853 
Donkey anti-Goat Alexa Fluor 647 ThermoFisher Scientific A21447, RRID:AB_141844 
Donkey anti-Rabbit Alexa Fluor 488 ThermoFisher Scientific A21206, RRID:AB_141708 
Donkey anti-Rabbit Alexa Fluor 555 ThermoFisher Scientific A31572, RRID:AB_162543 
Key Resource Table
Donkey anti-Mouse Alexa Fluor 555 ThermoFisher Scientific A31570, RRID:AB_2536180 
Donkey anti-Mouse Alexa Fluor 647 ThermoFisher Scientific A31571, RRID:AB_162542 
Goat anti-Rabbit Cy2 Jackson Immuno research # 111-225-144, RRID:AB_2338021 
Goat anti-Mouse Cy3 Jackson Immuno research #115-165-166, RRID:AB_2338692 
Goat anti-Mouse Cy5 Jackson Immuno research #115-175-166, RRID:AB_2338714 
Goat anti-Rat Alexa Fluor 647 ThermoFisher Scientific A21247, RRID:AB_141778 
Mouse anti-rabbit light chain specific IgG HRP Jackson Immuno research 211-032-171, RRID:AB_2339149 
Donkey anti-mouse IgG (H+L) HRP Jackson Immuno research 715-035-151, RRID:AB_2340771 
Rabbit serum IgG fraction Sigma Aldrich I5006, RRID:AB_1163659 
Protein A-10 nm Gold UMC Utrecht N.A. 
Goat anti-Mouse IgG 10 nm Gold BBI solutions Cat# EM.GMHL10 
Bacterial and Virus Strains  
XL-10 Gold Ultracompetent cells E.Coli Agilent Technologies #200315 
Biological Samples   
10-12–wpc human brain tissue Uniklinikum Dresden N.A. 
10-13–wpc human brain tissue HDBR N.A. 
15- and 16-wpc fixed human brain tissue HDBR N.A. 
Chemicals, Peptides, and Recombinant Proteins 
Cas9 WT protein, injection ready, lyophilized ToolGen Cat# TGEN_CP1 
Critical Commercial Assays 
Maxi prep kit Qiagen Cat#12362 
QuikChange Lightning Site-Directed Mutagenesis 
kit 
Agilent Technologies Cat#210518 
Lipofectamine 2000 Reagent Invitrogen Cat#11668-019 
Adducin γ CRISPR/Cas9 KO plasmid (h) Santa Cruz sc-417366 
Experimental Models: Cell Lines 
Mouse: Eph4-Ev cells ATCC Cat# ATCC® CRL- 3063TM 
Experimental Models: Organisms/Strains 
Mouse: C57BL/6JOlaHsd MPI-CBG N.A. 
Mouse: Palm1 KO (Albrecht et al., 2013) N.A. 
Ferret Mustela putorius furo Marshall Bioresources N.A. 
Ferret Mustela putorius furo Euroferret N.A. 
Oligonucleotides 
Palmd cloning primers, see Table S3 This paper N.A. 
Palmd mutagenesis primers, see Table S3 This paper N.A. 
LacZ gRNA: TGCGAATACGCCCACGCGAT (Kalebic et al., 2016) N.A. 
Palmd gRNAs, see Table S3 This paper N.A. 
CRISPR test Primers, see Table S3 This paper N.A. 
Recombinant DNA 
pCAG This paper N.A. 
pCAG-Palmd-Caax This paper N.A. 
pCAG-Palmd-KKVI This paper N.A. 
pCAG-Palmd-Delta This paper N.A. 
pCAG-GFP (Fei et al., 2014) N.A. 
pCAGGS-Lyn GFP (mGFP) Mod.from (Namba et al., 
2014) 
N.A. 
pCas9-LacZ DNA2.0  pD1321-AP:211150 
pCas9-gPalmd_cr1 DNA2.0 N.A. 
pCas9-gPalmd_cr2 DNA2.0 N.A. 
pCas9-gPalmd_cr3 DNA2.0 N.A. 
pSuper-Scrambled shRNA (Namba et al., 2014) N.A. 
pSuper-ITGB1 shRNA This paper N.A. 
Software and Algorithms 
Fiji/ImageJ Fiji/Imagej https://imagej.nih.gov/ij/ 
Imaris 8 BitPlane N.A. 
Prism GraphPad software N.A. 
ZEN Carl Zeiss N.A. 
TrakEM2 0.9a Imagej N.A. 
Geneious 11.0 Biomatters Ltd N.A. 
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A Mouse E13.5 + 16 h in vivo
Ki67 DAPI GFP Ki67 DAPI Ki67/GFP
Control PALMD-CaaX
DAPI Ki67/GFP DAPI Ki67/GFP
Control PALMD-CaaX
DAPI Ki67/GFP
+ 24 h ex vivo (DMSO) + 24 h ex vivo (2BrPal)
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11–13-wpc 3 d culture
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List of top 10 PALMD interactors 

































































































































































































































































































































































































D PALMD-CaaX + Control shRNA PALMD-CaaX + Itgb1 shRNA




















































































































































































Process splitting nearby the cell body H’ Process splitting away from the cell body
DAPI HOPX/ANLN
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Supplemental Text and Figures
Figure S2
A
No. prim. proc.:   5 1
No. all proc.:      6 1
branching index: 1.2 1.0
Sholl 2r:    6 1
Sholl 3r:    1 1
Sholl 4r:    0 1
BA’ mBP bRG-b
Ferret E35




















































































































































































DAPI PhVim merge DAPI PhVim merge DAPI PhVim merge
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DAPI Add3 Add3 DAPI/Add3
G’
F’
Human 12-wpc 3 d culture
Control ADD3 KO
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F Human 12-wpc 1 d culture
DAPI PCNA DAPI PCNA













































Table S1 Related to Figure 3. Genes enriched in the fetal human OSVZ/ISVZ vs. VZ/CP. 
Ensembl Gene ID Gene name VZ ISVZ OSVZ CP 
ENSG00000099260 PALMD 0,207 11,673 19,459 2,744 
ENSG00000214595 EML6 0,192 9,379 15,604 1,005 
ENSG00000099250 NRP1 0,642 22,726 47,852 4,285 
ENSG00000213906 LTB4R2 0,060 1,225 3,369 0,028 
ENSG00000123243 ITIH5 0,131 3,738 4,850 0,742 
ENSG00000091664 SLC17A6 0,372 19,615 13,617 0,103 
ENSG00000232044 AC073479.1 0,830 29,970 25,053 6,437 
ENSG00000137491 SLCO2B1 0,213 5,236 5,782 1,586 
ENSG00000182379 NXPH4 0,695 33,174 16,629 6,028 
ENSG00000100314 CABP7 0,437 9,916 9,203 3,330 
ENSG00000137801 THBS1 4,044 47,078 73,338 5,144 
ENSG00000124785 NRN1 4,446 147,496 76,222 29,823 
ENSG00000233863 AC012215.1 1,842 22,950 30,273 6,220 
ENSG00000183775 KCTD16 0,222 2,667 3,405 0,803 
ENSG00000044524 EPHA3 2,886 32,716 43,142 12,004 
ENSG00000106341 C7orf16 7,034 189,600 105,121 0,842 
ENSG00000173930 SLCO4C1 0,108 2,061 1,474 0,000 
ENSG00000244055 AC007566.10 0,565 5,786 7,666 2,538 
ENSG00000204624 PTCHD2 5,283 69,449 66,439 11,801 
ENSG00000117971 CHRNB4 0,278 4,494 3,366 0,186 
ENSG00000134531 EMP1 0,227 2,340 2,538 0,487 
ENSG00000080644 CHRNA3 0,186 3,504 2,017 0,000 
ENSG00000154133 ROBO4 0,268 3,218 2,793 0,752 
ENSG00000137142 IGFBPL1 23,305 263,791 240,633 65,951 
ENSG00000130429 ARPC1B 0,471 10,586 4,739 1,307 
 
Table S2 Related to Figure 6. List of Palmd interactors in hNcx, fNcx and mNcx 
HUMAN IP 




Exp. 1 Exp. 2 Exp. 3 Ferret 
IP 
Mouse 
IP UP TS UP TS UP TS 
Beta-adducin ADD2 81 30 140 21 68 23 115 yes yes 
Alpha-adducin ADD1 84 17 139 17 83 14 100 yes yes 
Kinesin KIF4A KIF4A 140 18 23 17 22 9 13 no no 
Flightless-1 homolog FLII 138 8 8 10 11 6 6 yes no 




LRRFIP1 86 6 10 5 6 1 1 no no 
Clathrin heavy chain 1 CLTC 188 1 1 8 9 3 3 yes no 
Palmdelphin PALMD 63 8 8 3 5 1 2 yes yes 
MAP2 MAP2 199 11 13 1 1 1 1 no no 
Protein O-GlcNAcase MGEA5 103 5 7 7 10 1 1 no no 
ADE2 PAICS 47 2 2 3 3 1 1 no no 
TFIID subunit 5 TAF5 87 1 1 3 4 2 2 yes no 
CSTF subunit 3 CSTF3 83 4 5 1 1 1 1 yes no 
Pyruvate kinase PKM 58 4 4 1 1 8 8 no no 
EPS15L1 EPS15L1 66 4 4 1 1 1 2 no no 
TFIID subunit 6 TAF6 110 2 3 1 1 1 1 no no 
Epididymis luminal 
protein 4 
YWHAZ 28 1 2 1 1 6 14 no no 





13 1 5 1 6 1 4 no no 
Stathmin STMN1 20 1 1 1 2 1 2 no no 
40S ribosomal protein 
S14 
RPS14 13 1 1 1 1 1 2 no no 
FERRET IP MOUSE IP 











Ppfia3 137 17 Nestin Nes 207 73 
Beta-adducin Add2 80 16 Treacle protein Tcof1 139 33 
Alpha-adducin Add1 85 13 Band 4.1-like 
protein 2 
Epb41l2 110 23 
Meningioma expressed 
antigen 5  
Mgea5 103 7 Alpha-adducin Add1 81 19 
Ceruloplasmin Cp 124 6 Beta-adducin Add2 81 17 
Flightless-1 homolog FliiI 145 6 ASH2 like Ash2l 68 16 
Malonyl-CoA 
decarboxylase 
Mlycd 39 6 BAG6 Bag6 121 15 
Complement C3 C3 188 5 Annexin A2 Anxa2 39 12 
Kinesin-like protein Kif2c 81 5 Gamma-tubulin 
complex comp. 3 
Tubgcp3 103 11 
TATA-box binding 
protein assoc. factor 5 
Taf5 87 5 Transglutaminase 
I 
Tgm1 90 11 
WD repeat domain 11 Wdr11 134 5 Rb-binding protein 
5 
Rbbp5 59 9 
Nucleotide binding 
protein like 
Nubpl 35 5 Gamma-tubulin 
complex comp. 2 
Tubgcp2 103 9 
Gamma-adducin Add3 79 4 Lamin-B receptor Lbr 71 8 
 
Table S3 Related to STAR Methods. List of oligonucleotides used. 
Oligonucleotide Sequence 
Palmd cloning primers 
Palmd cloning primer Palmd_SpHI_Fw AGATGCATGCGCCGCCATGGAAGAAGCTGAG 
Palmd cloning primer KKVI_BsrGI_Rev CCCGCTGTACATTAGATCACCTT 
Palmd cloning primer CAAX_BsrGI_Rev CCCGCTGTACATCACATGACTG 
Palmd mutagenesis primers 
Palmd mutagen. primer Del-C-sense CTGAGGATCCATCCTTAACAGCTTTAAGGATGAGAATGG 
Palmd mutagen. primer Del-C-antisense CCATTCTCATCCTTAAAGCTGTTAAGGATGGATCCTCAG 
Palmd gRNAs 
Palmd gRNA cr1 TGCCAAAAAAATATCAGTAACGG 
Palmd gRNA cr2 AGAAACTAAAGTCAATTGAGCGG 
Palmd gRNA cr3 AGCTTCACACCCCGCAAAAAAGG 
Palmd gRNA cr4 GCAGCATACAATGGCACCGATGG 
Palmd gRNA cr5 GCTTGTTGAATCACTGATCGGGG 
Palmd gRNA cr6 GAGTCATTAGCCTTTTTTGCGGG 
Palmd gRNA cr7 TGGGGTTGTAGGCCTGTAAAAGG 
CRISPR test primers 
CRISPR test Primer for PCR1 Fw GCTAGACTAATGGGGAAGAAGGA 
CRISPR test Primer for PCR1 Rev GTTGGCCTCCCCTATGGTTA 
CRISPR test Primer for PCR2 Fw ACTCCGCATTTGTACTGTGTT 
CRISPR test Primer for PCR2 Rev GGACTTTGGAAGGTCAGGGA 
CRISPR test Primer for PCR3 Fw CTTTGCCCACTGTGATGCAC 
CRISPR test Primer for PCR3 Rev TCACTGTCTTCTGCCTGCTG 
 
Figure S1 Related to Figure 1. Analyses of human proliferative BP morphology. 
(A) DAPI staining and IF for SOX2 and HOPX of 15-wpc hNcx. 
(B, C) DAPI staining and IF for SOX2 and BLBP of 15-wpc hNcx. (B) Overview. (C) Examples of 
bRG-bbf, bRG-abbf and mBP-p (see schemes). The 4 left-most images in each row are 50 μm 
wide, whereas each right image represents the area indicated by the respective box and is 
9.25 μm (bRG-bbf), 7 μm (bRG-abbf) or 10 μm (mBP-p) wide. Double arrow, single basal process 
leaving the cell body and bifurcating more basally into two processes; arrows, two basal 
processes either beyond the bifurcation point (bRG-abbf) or intertwined around each other 
(bRG-bbf); solid arrowhead, apical process; open arrowheads, short processes of the mBP-p. 
All images are oriented with the apical side facing down. 
(D-G) Sparse DiI labeling of 12-wpc hNcx from the basal side, combined with DAPI staining (in 
D and E). Boxes in (D) and (E), areas shown at higher magnification in (D') and (E'), respectively. 
(E') Enlarged view of the bRG-bbf; top, same orientation as in (E); middle and bottom, rotations 
by 45° and 90°, respectively, to demonstrate the 3-dimensional structure of the processes. 
See also supplemental movies 2 and 3. (F) Quantification of DiI+ radial processes of bRG with 
respect to the presence of a splitting site (for details, see Methods). (G) An example of a SOpS 
section of DiI-labeled 12-wpc hNcx. 
(H-H") Cell biological analysis of the human bRG morphotypes identified here – bRG-bbf and 
bRG-abbf (collectively termed bRG-(a)bbf). The IF and DiI labeling described in (A-G) and in 
Figure 1 had revealed that bRG-(a)bbf come in two different forms, (i) with two independent 
basal processes leaving the cell body (Figures 1A and S1E), and (ii) with a single basal process 
leaving the cell body, which then splits into two processes (Figures 1B and S1C middle). From 
a cell biological point of view, two basal processes can result from either splitting the originally 
single basal process in the apical direction, as previously reported for mouse neuroepithelial 
cells (Kosodo et al., 2008), or growing two separate processes from the cell body in the basal 
direction. Our observations suggest that both mechanisms might be occurring in human bRG. 
On the one hand, a cluster of anillin, a component of the cell cytokinesis machinery found at 
the basal process bifurcation site of mouse neuroepithelial cells (Kosodo et al., 2008), was 
readily found at the bifurcation site of human bRG-(a)bbf (H, H'). On the other hand, thick 
growth cone-like structures could sometimes be observed at the distal ends of basal processes 
of human bRG-(a)bbf (for a bRG-bbf example, see Figure 2C"), suggesting an active basally 
directed growth mechanism. (H, H') DAPI staining and IF for HOPX and ANILLIN (ANLN) of bRG-
(a)bbf in the OSVZ of 15-wpc hNcx. (H) Example of a cell with the basal process splitting nearby 
the cell body. (H') Example of a cell with the basal process splitting away from the cell body. 
Double arrows, bifurcation points with ANILLIN signal; arrows, two basal processes beyond 
the bifurcation point; arrowhead, apical process. All images are oriented with the apical side 
facing down. Images are two (H) or three (H') consecutive optical sections and are 25 μm wide. 
(H") Quantification of the position of the process splitting site in relation to the cell body of 
bRG-(a)bbf determined using the cluster of anillin. Note that about half of the bRG-(a)bbf split 
their basal process near the cell body and the other half away from the cell body. Of note, 
anillin spots were also present elsewhere in the cell including the cell body and as such cannot 
per se be used to predict process splitting sites. 
(I-N) In 15-16–wpc hNcx, the vast majority of progenitors is neurogenic, and gliogenic 
progenitors are not yet abundant (Jakovcevski et al., 2009). To label the gliogenic progenitors 
in the OSVZ of 15-16–wpc hNcx, we performed an IF for the transcription factor OLIG2. (I) DAPI 
staining and IF for SOX2, HOPX and OLIG2. All images are oriented with the apical side facing 
down. (J) Percentage of SOX2+ and HOPX+ cells that are OLIG2+. Note that at this stage only 
10% of proliferative BPs were gliogenic (K) Percentage of OLIG2+ cells that are SOX2+ and 
HOPX+. (L) Percentage of SOX2+ and HOPX+ cells that exhibit processes. (M) Distribution of 
mBP vs. bRG morphotypes of OLIG2+, SOX2+ and HOPX+ cells. Note that 60% of gliogenic 
progenitors exhibited a multipolar and 40% a radial morphology. (N) DAPI staining and IF for 
SOX2, HOPX and OLIG2 of a bRG-a and a mBP-p. All images are oriented with the apical side 
facing down. Arrowheads, cell body; arrows, processes. All images are 35 μm wide. 
(A-E', G, I, N) MIPs (A, 37 optical sections; C, bRG-abbf and mBP-p, 3 optical sections; D'; E; E'; 
I, 6 optical sections; N, 6 optical sections), SOpS (B; C, bRG-bbf; D), StIs. Scale bars, 100 μm (D, 
G), 50 μm (A, B, E, I), 20 μm (D'), 10 µm (E'). 
(F, H", J-M) Mean of 2 (J-M), 4 (H", two 12-wpc and two 15-wpc hNcx) or 5 (F) experiments. 
Total number of cells scored: 58 (H"), 132 (L). Error bars, SD (F, H") or range (J-M). 
 
Figure S2 Related to Figure 2. Quantitative analyses of BP morphotypes across different 
mammals. 
(A-F) E13.5 mNcx, E33 fNcx and 10-13–wpc hNcx tissue were electroporated as detailed in 
Figure 2A-C. 
(A, A') Example of cell tracking (segmentation). IF for mGFP (grey) of E15.5 mNcx. BPs in the 
SVZ and IZ were tracked and cell masks representing cell shape were generated (colored). (A) 
Overview. Box (100 μm x 100 μm), area shown at higher magnification in (A'). 
(B) Examples of BP process analysis. Cell masks representing cell shape of an E35 ferret mBP 
(left) and bRG-b (right) were generated by tracking the mGFP IF (see Figure 2B), and cell 
processes were analyzed using the Progenitors Process Analysis (PPA) software (see 
Methods). Red contour, cell soma; green, primary processes; dark blue, branches (secondary 
processes). Concentric circles with their midpoints at the center of the cell soma and gradually 
increasing by the soma radius (2r, 3r and 4r) were used for the Sholl analysis – the 
quantification of the number of process intersections with the concentric circles. List of 
parameters and measurements is given in the table on the right. Number of all processes 
equals the number of all primary processes plus all the branches. Branching index is calculated 
by dividing the number of all processes by the number of primary processes and can be 1.0 or 
higher. Additionally, the PPA software measures also the length of each process (not shown). 
(C, D) DAPI staining and IF for mGFP and Ki67 (C) or Pax 6 (D) of E15.5 mNcx. Arrowheads, 
examples of mGFP+ BPs. (D right, low magnification panels, 30 µm wide), an mGFP+ Pax6+ 
radially-oriented cell indicated with arrowheads. Arrows, basal process; dashed line, cell body. 
(E) Quantification of mBP branching expressed as the branching index (see B) per single mGFP-
tracked mBP. 
(F) DAPI staining and IF for GFP of a bRG-bbf in 12-wpc hNcx. Arrows, basal processes; 
arrowhead, cell body. Note that one of the basal processes reaches the basal lamina. 
(G-J) IF for Hopx to analyze bRG morphology and for Sox2 to identify proliferative BPs of E15.5 
mNcx and 12-15–wpc hNcx, followed by analyses as indicated. (G) Distribution of the 5 bRG 
morphotypes in 12-15–wpc hNcx, as shown schematically on the right. Note that the 
distribution bRG morphotypes is comparable to the one obtained by mGFP tracking (compare 
to Figure 2F right). (H, I) DAPI staining and IF for Sox2 and Hopx of E15.5 mNcx. (H) Overview 
images. Arrows, example of a bRG-b; solid arrowheads, example of a bRG-a; open arrowheads, 
example of an mBP-p. (I) Three mouse bRG morphotypes. All images are oriented with the 
apical side facing down and are 50 μm wide. Dashed lines, cell contours; arrows, basal process; 
arrowheads, apical process. (J) Distribution of the three bRG morphotypes in E15.5 mNcx, as 
shown schematically on the right. Note that this analysis showed that indeed mouse lacks 
bRG-bbf and bRG-abbf and that the relative proportion of the other three bRG morphotypes is 
very similar to that obtained by mGFP tracking (compare to Figure 2F left). 
(K-N) Analysis of mitotic BPs in mNcx. DAPI staining and IF for PhVim of E15.5 mNcx, followed 
by analyses as indicated. (K) Overview images. (L) Three mouse mitotic bRG morphotypes. 
Images are are 30 μm wide. (M) Distribution of mitotic bRG vs. mitotic mBP morphotypes in 
the SVZ+IZ of E15.5 mNcx (20 consecutive optical sections of 400-μm wide fields). Note that 
the proportion of mBPs and bRG is comparable to the one obtained by mGFP tracking 
reflecting BPs in all stages of the cell cycle (compare to Figure 2D left). (N) Distribution of three 
different mouse mitotic bRG morphotypes, as shown schematically on the right. Note that the 
distribution bRG morphotypes is comparable to the one obtained by mGFP tracking (compare 
to Figure 2F left) and by IF for Hopx (compare to Figure S2J), both reflecting BP at all stages of 
the cell cycle. 
(O, P) Analysis of lamellate expansions in fNcx and hNcx. E33 fNcx and 10-13–wpc hNcx tissue 
were electroporated as detailed in Figure 2B, C. (O) IF for GFP of a bRG-b in 12-wpc hNcx. The 
cell shape as tracked by GFP IF is depicted in the right panel. Arrows, lamellate expansions 
extending from the cell soma and along the basal process. Image is 25 μm wide. (P) Percentage 
of bRG with lamellate expansions in E35 fNcx and 10-13–wpc hNcx. 
(A, C, D, F, H, I, K, L, O) MIPs (A, 35 optical sections; F and K, 20 optical sections; I, 3 optical 
sections; L, 4 (bRG-b), 6 (bRG-a) and 7 (bRG-ab) optical sections; O, 5 optical sections), SOpS 
(H), StIs. Scale bars, 100 μm (A, K), 50 μm (H), 30 μm (F), 20 µm (C, D). 
(E, G, J, M, N, P) Mean of 8 (E, mouse; M; N), 4 (E and P, ferret; J) 7 (E and P, human), 3 (G, one 
12-wpc and two 15-wpc hNcx) experiments. Total number of cells scored: 197 (M), 169 (G), 
80 (E, mouse), 43 (E, ferret), 48 (E, human), 29 (J), 19 (N). Error bars, CI (E, G, J, M, N) or SEM 
(P); **, P <0.01; *, P <0.05; n.s., not statistically significant; Student's t-test (E), 2-way ANOVA 
(P). 
 
Figure S3 Related to Figure 3. The morpho-regulatory protein PALMD-CaaX induces BP 
process growth in mNcx and fNcx. 
(A) mRNA expression of the Palmdelphin (Palmd) gene, analyzed by RNA-seq in mNcx and 
hNcx. RNA-seq data for germinal zones (upper panels) are from (Fietz et al., 2012) and for cell 
types (lower panels) are from (Florio et al., 2015). Developmental stages: E14.5 mouse (Fietz 
et al, 2012 and Florio et al, 2015); 12-13–wpc human (Florio et al, 2015), 13-16–wpc human 
(Fietz et al, 2012). All the comparisons that are not marked by asterisks are not statistically 
significant. Note that in the hNcx, PALMD mRNA was most highly expressed in the ISVZ and 
OSVZ , and accordingly in bRG . In the mNcx, Palmd mRNA was found in both the VZ and SVZ, 
with the highest relative expression in APs. 
(B-D) DAPI staining and IF for PCNA and Palmd of E15.5 mNcx (B), E36 fNcx (C) and 16-wpc 
hNcx (D). 
(E) mRNA expression of the two Palmd isoforms, Palmd-CaaX and Palmd-KKVI, analyzed by 
RNA-seq in mNcx and hNcx. RNA-seq data are from (Florio et al., 2015). All the comparisons 
that are not marked by asterisks are not statistically significant. Note that in human 
progenitors both PALMD isoforms are present, whereas mouse progenitors virtually lack the 
expression of the PM-associated isoform (Palmd-CaaX). 
(F-G) DAPI staining and IF for cadherin and Palmd of E15.5 mNcx (F) and 11-wpc hNcx (G); (G) 
shows a cell in the OSVZ. Arrowheads, lack of colocalization of cytoplasmic Palmd/PALMD with 
PM-bound cadherin; arrows, co-localization of PALMD with CADHERIN on the PM (human). 
Boxes (50 x 50 μm and 15 x 15 μm) in (F) and (F'), areas shown at higher magnification in (F') 
and (F''), respectively. 
(H-Q) Analyses of mNcx (H-L, P left, Q) and fNcx (M-O, P right) upon IUE with mGFP and control 
or PALMD isoforms as indicated. (I-L, O, P) Quantification of processes of mouse and ferret 
BPs and APs as tracked by mGFP IF. 
(H) DAPI staining and IF for GFP and PALMD of E15.5 mNcx upon PALMD-CaaX IUE as indicated. 
Boxes indicate areas shown at higher magnification in H'. (H') Arrows, co-localization of 
PALMD-CaaX and mGFP on the PM. 
(I) Distribution of BP morphotypes. 
(J) Quantification of mBP branching expressed as the branching index per single mBP. 
(K) Sholl analysis of mBPs. Note that PALMD-CaaX induces preferentially short processes (2r 
distance). 
(L) Histogram of the frequency distribution of process length upon control  and PALMD-CaaX 
IUE. The length of all the processes tracked on 25 mBPs (Control) or 28 mPBs (PALMD-CaaX) 
were binned into 24 bins (X axis), with bin 1 indicating the shortest and bin 24 the longest 
processes. The number of processes in each bin is presented on the Y axis. Compared to 
control, PALMD-CaaX induces preferentially short processes (bins 2 - 6). Total number of 
processes scored: control 87, PALMD-CaaX 127. 
(M) DAPI staining and IF for GFP and PALMD of E35 fNcx upon PALMD-CaaX IUE as indicated. 
(N) DAPI staining and IF for GFP and Pax6 of E35 fNcx. Arrowheads, example of a bRG-a; double 
arrows, example of a bRG-ab. Higher magnification images (20 μm wide) of the indicated bRG 
are shown on the right; arrows indicate the process(es) of the bRG-a from the control 
condition (top) and the bRG-ab from the PALMD-CaaX condition (bottom). 
(O) Quantification of mBP branching expressed as the branching index per single mBP. 
(P) Quantification of AP (aRG, apical radial glia) morphotypes in interphase in E15.5 mNcx and 
E35 fNcx. Interphase cells were defined as those aRG whose cell body is located away from 
the ventricle. Confining the quantification to aRG in interphase allowed determining the 
effects of PALMD-CaaX expression on aRG morphology in steady state, while excluding 
changes in their morphology due to entry into mitosis. Note that all cells exhibit bipolar 
morphology (aRG-ab, shown schematically on the right) in both conditions in both species. 
(Q) DAPI staining and IF for GFP, PhVim and PALMD in E15.5 mNcx upon PALMD-CaaX IUE as 
indicated. Arrows, PALMD-CaaX present in short processes that do not contain PhVim. Images 
are 30 μm wide. Note that similarly to interphase mBPs, PALMD-labeled processes of mitotic 
mBPs appeared to be short and relatively thin as they appeared to lack cytoplasmic PhVim 
immunoreactivity. 
(B-D, F-H', M, N, Q) MIPs (B-D, 7 optical sections; H and H', 5 optical sections; M, 3 optical 
sections), SOpS (F-G, N, Q), StIs. Scale bars, 100 μm (H, M), 50 μm (B-D, F, N), 20 μm (F', H'), 
10 μm (F", G). 
(A, E, I-L, O, P) Mean of 4 (E), 4-6 (A) biological replicates or 3 (L, P), 5 (O), 8 (I-K) experiments. 
Total number of cells scored: 88 (I, control), 87 (I, PALMD), 80 (J and K, control), 79 (J and K, 
PALMD), 31 (O, control), 34 (O, PALMD), 12 (P, mouse), 10 (P, ferret). Error bars, SD (A, E) or 
CI (I-K, O, P); ****, P <0.0001; ***, P <0.001; **, P <0.01; *, P <0.05; not statistically significant; 
two-way ANOVA(I, P), one-way ANOVA with Dunnett's multiple comparisons test (A), 
Student's t-test (E, J, K, O). 
 
Figure S4 Related to Figure 4. PALMD-CaaX promotes BP proliferation in mNcx and fNcx. 
Analyses of mNcx (A, DF) and fNcx (B, C) upon IUE with mGFP and control or PALMD isoforms 
as indicated. 
(A) DAPI staining and IF for GFP, Ki67 and PhVim of E15.5 mNcx. Arrowheads, examples of 
GFP+ mitotic BPs. 
(B) DAPI staining and IF for GFP and PH3 of E35 fNcx. Vertical arrows, examples of apical 
mitoses; horizontal arrows, examples of basal mitoses. 
(C) Quantification of apical and basal mGFP+ PH3+ mitoses.  
(D) Quantification of apical mGFP+ PH3+ mitoses (see Figure 4H for microscopy images). 
(A, B) SOpS, StIs. Scale bars, 20 μm. 
(C, D) Mean of 5 (C), 8 (D, control and PALMD-CaaX), 4 (D, PALMD-KKVI and PALMD-') 
experiments. Error bars indicate SD; *, P <0.05; n.s., not statistically significant; Mann-Whitney 
U-test. 
 
Figure S5 Related to Figure 5. PALMD is required for BP process growth and proliferation in 
hNcx. 
(A) hNcx tissue was electroporated ex vivo with mGFP and soluble GFP, kept in culture and 
incubated in the absence (DMSO) or presence of 2BrPal as indicated in Figure 5E. Analysis of 
the 5 bRG morphotypes, as shown schematically on the right. 
(B) Schematic representation of the transcribed region of the PALMD gene. Green boxes, 
exons; green arrow, transcription start site (TSS); orange box, differentially spliced last 
protein-coding exon (CaaX or KKVI). Bottom schemes show magnifications of the three regions 
of PALMD with the positions of the individual gRNAs (cr1-7, red). Cr1 guides cutting in intron 
1 (I1), cr2 in exon 4 (E4) and cr3-7 in exon 7 (E7). 
(C) Agarose gel showing the effects of the gRNAs cr1-7 described in (B) to direct Cas9-
mediated cutting of three PALMD PCR products in vitro. PCR1, PCR2 and PCR3-7 indicate 
template-only control with no gRNA added (cr1, cr2, cr3, respectively); M, DNA size marker. 
gRNAs selected for the ex vivo experiments are: cr1 (located most 5’ within the PALMD gene, 
which increases the probability of obtaining disruption of gene expression), cr2 and cr3 (both 
have stronger efficiency of cutting the respective PCR product according to the in vitro test 
presented than cr4-7). 
(D -J) hNcx tissue was electroporated ex vivo with mGFP and soluble GFP together with 
plasmids encoding Cas9_T2A_RFP and gRNA targeting either LacZ (Control) or PALMD (PALMD 
KO), as indicated. 
(D) DAPI staining and IF for PALMD and RFP (reflecting Cas9) of 11-wpc hNcx. Dashed lines, 
cell outline reflecting the region of interest (ROI) used for the quantification of IF intensity; 
yellow arrowheads, lack of PALMD signal on the PM of the Cas9+ cell; white arrowheads, 
PALMD signal on the membrane of a Cas9– cell. Upper two images are 50 µm wide. Box (10 
µm wide), area shown at higher magnification below.  
(E) Quantification of PALMD immunoreactivity, measured as mean pixel intensity value per 
RFP+ SVZ cell. The mean of the data points of the control condition was set to 100%, and the 
data points of the KO condition were expressed relative to this. Each data point indicates the 
average value obtained per one tissue section. 
(F, G) Analysis of cell death. (F) DAPI staining and IF for GFP and active CASPASE-3. (G) 
Quantification of cell death, shown as abundance of active CASPASE-3+ cells in a 200 µm-wide 
field. Note that the present approach of ex vivo manipulation did not cause an increase in cell 
death. 
(H) Quantification of the efficiency of electroporation, shown as abundance of Cas9+ cells in 
a 200 µm-wide field. Note that the present approach of ex vivo manipulation was equally 
efficient for both PALMD KO and control constructs. 
(I, J) Quantification of processes of BPs as tracked by mGFP IF. (I) Distribution of bRG vs. mBP 
morphotypes. (J) Quantification of mBP branching expressed as the branching index per single 
mBP. 
(D, F) SOpS , StI (F). Scale bar, 100 µm (F). 
(A, E, G-J) Mean of 7 (H), 6 (I, J), 5 (G), 3 (A, E) experiments. Total number of cells scored: 66 
(I, control), 59 (I, PALMD KO), 35 (J, control), 31 (J, PALMD KO), 33 (A, control), 25 (A, 2BrPal). 
Error bars, CI (A, I, J) or SD (G, H); ***, P <0.001; n.s., statistically not significant; two-way 
ANOVA (A, I), Mann-Whitney U-test (E), Student's t-test (G, H, J). 
 
Figure S6 Related to Figure 6. Specificity of PALMD and identification of adducin 3 as 
essential component in the PALMD-induced increase in BP processes. 
(A-D) Analysis of specificity of PALMD-CaaX on BP morphology and BP proliferation. To 
examine if another paralemmin was able to recapitulate the effects of PALMD-CaaX on BP 
morphology and proliferation, we focused on Palm1, the founding member of this family, 
which also contains a CaaX domain (Kutzleb et al., 1998). As Palm1 is expressed in mouse BPs 
(A), we used the Palm1 KO mouse line (Albrecht et al., 2013). Our analyses (B) showed that 
Palm1 is not required to maintain the normal levels of mBP process number (C) and of BP 
proliferation (D) in mNcx. Hence, although Palm1 has been shown to promote cell process 
formation in neurons (Gauthier-Campbell et al., 2004; Kutzleb et al., 1998), its lack of effects 
in mouse BPs suggests that the ability of human PALMD-CaaX to promote BP process growth 
and proliferation may well be a specific feature of PALMD-CaaX. (A) mRNA expression of the 
paralemmin 1 (Palm1) gene, analyzed by RNA-seq in mNcx. RNA-seq data are from (Florio et 
al., 2015). (B-D) Wild type and homozygous Palm1 KO mNcx upon IUE of mGFP at E13.5, 
followed by analysis at E15.5. (B) DAPI staining and IF for GFP and Ki67. Boxes (30 µm x 30 
µm), areas shown at higher magnification on the right. Arrows, cell processes. (C) 
Quantification of primary processes per single mBP. (D) Percentage of mGFP+ cells in SVZ+IZ 
that are Ki67+. 
(E-J) Identification of adducin 3 as essential component in the PALMD-induced increase in BP 
processes. (E) mRNA expression of the adducin3 (Add3) gene, analyzed by RNA-seq in mNcx 
and hNcx. RNA-seq data for germinal zones (upper panels) are from (Fietz et al., 2012) and for 
cell types (lower panels) are from (Florio et al., 2015). Note that in mNcx Add3 mRNA is found 
in only low quantities and mostly in the VZ and in aRG, whereas in hNcx, ADD3 mRNA is highly 
expressed in the VZ, ISVZ and OSVZ and in both aRG and bRG, that is, in the most proliferative 
zones and cell populations of these two species. (F) DAPI staining and IF for Palmd and 
adducin-J (Add3) of E15.5 mNcx. Asterisks, background staining in the IZ. (G) DAPI staining 
amd IF for Add3 of OSVZ of E37 fNcx. Box, area shown at higher magnification in (G'). Note 
that Add3 was observed at the cell periphery, consistent with an association with the PM. (H) 
Entire immunoblots, using anti-PALMD (left) and anti-ADD3 (right) antibodies, of 12-wpc hNcx 
tissue immunoprecipitates (IP) obtained using control, anti-PALMD and anti-ADD3 antibodies. 
Arrowheads, PALMD band (left) and ADD3 band (right); arrows, IgG heavy chain; double 
arrows, IgG light chain. Note that a cropped section of this immunoblot is shown in Figure 6B. 
(I, J) hNcx tissue was electroporated ex vivo with mGFP together with plasmids encoding 
Cas9_T2A_GFP and gRNA targeting either LacZ (Control) or ADD3 (ADD3 KO), as indicated. (I) 
DAPI staining and IF for GFP (reflecting Cas9), Ki67 and ADD3. (J) Quantification of ADD3 
immunoreactivity, measured as mean pixel intensity value per GFP+ SVZ cell. The mean of the 
data points of the control condition was set to 100%, and the data points of the KO condition 
were expressed relative to this. Each data point indicates the average value obtained per one 
tissue section. 
(B, F-G', I) SOpS, StIs (B, F, I). All images are oriented with the apical side facing down. Scale 
bars, 50 μm (F), 20 µm (B, G, I), 10 μm (G').  
(A, C-E, J) Mean of 3 experiments (C, D, J) or 4-6 biological replicates (A, E). Total number of 
cells scored: 17 (C, control and Palm1KO). Error bars, SD (A, D) or CI (C); **, P <0.01; n.s., not 
statistically significant; Student's t-test (C), Mann-Whitney U-test (D, J). 
 
Figure S7 Related to Figure 7. The PALMD-CaaX–promoted increase in BP proliferation 
requires integrin-E1. 
(A, B) Analyses of mNcx upon IUE with mGFP and control or PALMD-CaaX as indicated. DAPI 
staining and IF for GFP and phospho-Akt (pAkt, A) or phospho-ERK (pERK, B). Boxes in (A) (50 
µm x 50 µm) and the numbered boxes in (B) (30 x 30 μm), areas shown at higher magnification 
below respective panels. Arrows, pAkt signal in the process of a GFP+ cell (A), arrowheads, 
pAkt (A) and pERK (B) signal in the cell body of a GFP+ cell. Immunoreactivity is quantified in 
Figure 7C. 
(C-E) Analyses of mNcx upon IUE with mGFP and PALMD-CaaX together with a plasmid 
encoding either scrambled shRNA (Control) or shRNA targeting Itgb1 as indicated. (C, D) DAPI 
staining and IF for GFP and Itgb1. (C) Overview images. (D) Images of electroporated areas. In 
(C), the dashed lines indicate the center of the electroporated area; note the reduced Itgb1 
signal in the electroporated area and the stronger Itgb1 signal outside (to the left) of the 
electroporated area; asterisks, Itgb1 staining of blood vessels. (E) Quantification of Itgb1 
immunoreactivity, determined as described in Methods. 
(F, G) 12–wpc hNcx tissue was kept in culture for one day and subsequently incubated for one 
day with Itgb1-blocking antibody (P5D2) as described in Methods. (F) DAPI staining and IF for 
PCNA. (G) Quantification of PCNA+ cells in both germinal zones (GZ, left), in the VZ (middle) 
and in the SVZ (right). 
(A-D, F) SOpS, StIs. Scale bars, 100 µm (C), 50 µm (F), 20 μm (A, B, D). 
(E, G) Mean of 4 (E) or 3 (G) experiments. Error bars, SD; ***, P <0.001; **, P <0.01; Mann-
Whitney U-test (E), Student's t-test (G). 
  
Table S1 Related to Figure 3. Genes enriched in the fetal human OSVZ/ISVZ vs. VZ. 
List of the 25 genes with at least 10-fold greater mRNA expression in the fetal human OSVZ 
and ISVZ than the VZ (Fietz et al., 2012). The list comprises Ensembl Gene IDs, gene names and 
average FPKM values in VZ, ISVZ, OSVZ and CP. Genes are listed in descending order by the 
fold-increase OSVZ/VZ. Seven genes related to cell morphology are highlighted in green. 
 
Table S2 Related to Figure 6. List of PALMD interactors in hNcx, fNcx and mNcx. 
Upper part. List of the proteins, with their respective gene name and molecular weight (MW), 
identified by MS in the three PALMD IPs (Exp. 1-3) and in neither of the control IPs from hNcx. 
For each protein and experiment, the number of unique peptides (UP) and the number of total 
spectra (TS) are given. Proteins are listed in descending order by their average UP number in 
the three experiments. The last two columns indicate whether the specific orthologue was 
found in the PALMD IP from fNcx (Ferret IP) or mNcx (Mouse IP), but not in the respective 
control. Members of the adducin family are highlighted in green, and the bait, PALMD, is 
highlighted in blue. 
Lower part. List of the top (see below) 13 proteins identified by MS in the Palmd IPs, but not 
in the control IPs, from fNcx (left) and mNcx (right). For each protein, the respective gene 
name, molecular weight (MW) and the number of unique peptides (UP) are given. Proteins 
are listed in descending order by the number of UPs. Note that the bait, Palmd, matched with 
lower number of UPs than the presented proteins, but it was specifically detected in Palmd 
but not control IP from both fNcx and mNcx. Note also that Add3 was not detected in the IP 
from mNcx. 
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